6-Hydroxydopamine hydrobromide
| Title | Journal |
|---|---|
| Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins. | Chemico-biological interactions 20180105 |
| An autophagic mechanism is involved in the 6-hydroxydopamine-induced neurotoxicity in vivo. | Toxicology letters 20171005 |
| Early expression of the receptor for advanced glycation end products in a toxic model produced by 6-hydroxydopamine in the rat striatum. | Chemico-biological interactions 20160405 |
| Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. | Neuropharmacology 20150801 |
| Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease. | Journal of molecular neuroscience : MN 20150301 |
| Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor. | Journal of neural transmission (Vienna, Austria : 1996) 20150201 |
| Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. | Chemico-biological interactions 20150105 |
| Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K/Akt/NF-κB pathway and protects against neurotoxicity. | Chemical research in toxicology 20141117 |
| Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by α-iso-cubebenol. | Neurotoxicology 20140901 |
| Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures. | Neurotoxicology 20140301 |
| Impairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicity. | Toxicological sciences : an official journal of the Society of Toxicology 20131101 |
| Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. | Nature cell biology 20131001 |
| AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model. | ACS chemical neuroscience 20130918 |
| Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease. | Neurotoxicology 20130501 |
| Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia. | Neuropharmacology 20130301 |
| A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons. | CNS neuroscience & therapeutics 20130301 |
| Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. | The Journal of toxicological sciences 20130201 |
| Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo. | Neuro-degenerative diseases 20130101 |
| Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease. | Neurotoxicology 20130101 |
| 7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease. | Neuropharmacology 20121201 |
| Chemical and biological evaluation of nephrocizin in protecting nerve growth factor-differentiated PC12 cells by 6-hydroxydopamine-induced neurotoxicity. | Phytochemistry 20121201 |
| Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Neuropharmacology 20121201 |
| Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis. | Journal of neuroscience research 20121201 |
| Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride. | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20121201 |
| Serotonergic neuroepithelial cells of the skin in developing zebrafish: morphology, innervation and oxygen-sensitive properties. | The Journal of experimental biology 20121115 |
| Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. | Journal of molecular neuroscience : MN 20121101 |
| GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones. | Journal of neuroendocrinology 20121101 |
| Insulin-like growth factor-1 inhibits 6-hydroxydopamine-mediated endoplasmic reticulum stress-induced apoptosis via regulation of heme oxygenase-1 and Nrf2 expression in PC12 cells. | The International journal of neuroscience 20121101 |
| Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway. | Journal of neurochemistry 20121101 |
| 6-Hydroxydopamine upregulates iron regulatory protein 1 by activating certain protein kinase C isoforms in the dopaminergic MES23.5 cell line. | The international journal of biochemistry & cell biology 20121101 |
| Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors. | The European journal of neuroscience 20121101 |
| Altered transcription factor trafficking in oxidatively-stressed neuronal cells. | Biochimica et biophysica acta 20121101 |
| Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells. | Biochimica et biophysica acta 20121101 |
| Novel codrugs with GABAergic activity for dopamine delivery in the brain. | International journal of pharmaceutics 20121101 |
| 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats. | Brain research 20121005 |
| Eppendorf finalist. Striatal interneurons: causes of or cures for movement disorders? | Science (New York, N.Y.) 20121005 |
| Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20121003 |
| Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease. | The Journal of nutritional biochemistry 20121001 |
| Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20121001 |
| Alcoholic extract of Bacopa monniera Linn. protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: a pilot study. | Cellular and molecular neurobiology 20121001 |
| Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase. | Neurochemical research 20121001 |
| Characterization of mitophagy in the 6-hydoxydopamine Parkinson's disease model. | Toxicological sciences : an official journal of the Society of Toxicology 20121001 |
| Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions. | Neuropeptides 20121001 |
| Immunohistochemical and morphological changes in neurons and neuroglia in the cerebral nigrostriatal structures under conditions of experimental nigral neurodegeneration. | Bulletin of experimental biology and medicine 20121001 |
| Visualizing dopamine transporter integrity with iodine-123-FP-CIT SPECT in combination with high resolution MRI in the brain of the common marmoset monkey. | Journal of neuroscience methods 20120930 |
| A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study. | Journal of neuroscience methods 20120930 |
| SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson's disease. | Journal of ethnopharmacology 20120928 |
| Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats. | Toxicology letters 20120918 |
| Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. | Chemical research in toxicology 20120917 |
| Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. | Neurobiology of aging 20120901 |
| Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias. | Neurobiology of aging 20120901 |
| Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats. | Pharmaceutical research 20120901 |
| Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. | Neurobiology of disease 20120901 |
| Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease. | Journal of molecular neuroscience : MN 20120901 |
| DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats. | Brain research bulletin 20120901 |
| Activation of subthalamic alpha 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing. | Neurobiology of disease 20120901 |
| Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation. | Journal of neurochemistry 20120901 |
| Do α-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model? | Experimental neurology 20120901 |
| RETRACTED: S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades. | Free radical biology & medicine 20120901 |
| L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease. | Neuroscience 20120830 |
| Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. | Brain research 20120830 |
| Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model. | Brain research 20120827 |
| Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways. | Journal of agricultural and food chemistry 20120822 |
| Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death. | Free radical biology & medicine 20120815 |
| Circadian rhythms of gastrointestinal function are regulated by both central and peripheral oscillators. | American journal of physiology. Gastrointestinal and liver physiology 20120815 |
| Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity. | Neuroscience letters 20120815 |
| Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120815 |
| Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling. | Neuroscience 20120802 |
| Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease. | Age (Dordrecht, Netherlands) 20120801 |
| Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine. | Neurotoxicity research 20120801 |
| Effect of quercetin and its glucuronide metabolite upon 6-hydroxydopamine-induced oxidative damage in Neuro-2a cells. | Free radical research 20120801 |
| Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease. | British journal of pharmacology 20120801 |
| 2-Benzazepine nitrones protect dopaminergic neurons against 6-hydroxydopamine-induced oxidative toxicity. | Archiv der Pharmazie 20120801 |
| High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: no role for serum level of homocysteine. | Behavioural brain research 20120801 |
| L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients. | Medical hypotheses 20120801 |
| The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine. | Die Pharmazie 20120801 |
| Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat. | Neuroscience 20120726 |
| Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls. | Behavioural brain research 20120715 |
| Enhanced expression of nesfatin/nucleobindin-2 in white adipose tissue of ventromedial hypothalamus-lesioned rats. | Neuroscience letters 20120711 |
| Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. | Neurotoxicity research 20120701 |
| Effect of oxytocin on neuroblastoma cell viability and growth. | Cellular and molecular neurobiology 20120701 |
| Sympathetic denervation of one white fat depot changes norepinephrine content and turnover in intact white and brown fat depots. | Obesity (Silver Spring, Md.) 20120701 |
| Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation. | Molecular medicine reports 20120701 |
| Renal sympathetic nerve activity during asphyxia in fetal sheep. | American journal of physiology. Regulatory, integrative and comparative physiology 20120701 |
| Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress. | American journal of physiology. Cell physiology 20120701 |
| 6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatum. | Behavioural brain research 20120615 |
| Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L). | Behavioural brain research 20120615 |
| Positive allosteric modulation of α4β2 nAChR agonist induced behaviour. | Brain research 20120606 |
| Neurotoxin-based models of Parkinson's disease. | Neuroscience 20120601 |
| Cranial and related sensorimotor impairments in rodent models of Parkinson's disease. | Behavioural brain research 20120601 |
| Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study. | Neuroscience research 20120601 |
| Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy. | Journal of neuroscience research 20120601 |
| Low level of glutathione can intensify the toxic effect of salsolinol in SH-SY5Y neuroblastoma cell line. | Neurotoxicology 20120601 |
| Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. | Brain : a journal of neurology 20120601 |
| Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease. | Neuroscience bulletin 20120601 |
| The effects of short-term nicotine administration on behavioral and oxidative stress deficiencies induced in a rat model of Parkinson's disease. | Psychiatria Danubina 20120601 |
| Proteomic analysis reveals a protective role for DJ-1 during 6-hydroxydopamine-induced cell death. | Biochemical and biophysical research communications 20120525 |
| NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. | Antioxidants & redox signaling 20120515 |
| Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease. | NeuroImage 20120515 |
| Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia. | European journal of pharmacology 20120515 |
| Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression. | Journal of neuroimmunology 20120515 |
| Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease. | Behavioural brain research 20120501 |
| Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease. | Journal of molecular neuroscience : MN 20120501 |
| Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat. | Neurochemical research 20120501 |
| Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501 |
| Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease. | Pharmacological research 20120501 |
| Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease. | Experimental neurology 20120501 |
| Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. | Neurobiology of learning and memory 20120501 |
| Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat. | The Journal of pharmacy and pharmacology 20120501 |
| In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120501 |
| Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120425 |
| Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat. | Brain research 20120423 |
| Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: effects on sensorimotor gating. | Behavioural brain research 20120421 |
| Functional neuroimaging of the 6-OHDA lesion rat model of Parkinson's disease. | Neuroscience letters 20120404 |
| Combined elemental and biomolecular mass spectrometry imaging for probing the inventory of tissue at a micrometer scale. | Analytical chemistry 20120403 |
| Neurotrophic effects of growth/differentiation factor 5 in a neuronal cell line. | Neurotoxicity research 20120401 |
| L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats. | Neurotoxicity research 20120401 |
| Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion. | Neurotoxicity research 20120401 |
| Toxicity of 6-hydroxydopamine: live cell imaging of cytoplasmic redox flux. | Cell biology and toxicology 20120401 |
| Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat. | Behavioural pharmacology 20120401 |
| Animal models of Parkinson's disease. | The FEBS journal 20120401 |
| Selective bilateral lesion to caudate nucleus modulates the acute and chronic methylphenidate effects. | Pharmacology, biochemistry, and behavior 20120401 |
| The effects of nigrostriatal dopamine depletion on the thalamic parafascicular nucleus. | Brain research 20120329 |
| Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120321 |
| The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease. | Journal of physiology and biochemistry 20120301 |
| Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model. | Molecular therapy : the journal of the American Society of Gene Therapy 20120301 |
| Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. | Cognitive, affective & behavioral neuroscience 20120301 |
| Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons. | Shock (Augusta, Ga.) 20120301 |
| Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence. | Neurochemical research 20120301 |
| Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death. | Journal of neuroscience research 20120301 |
| Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning. | Journal of neurochemistry 20120301 |
| Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites. | Behavioural brain research 20120301 |
| Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease. | Apoptosis : an international journal on programmed cell death 20120301 |
| Evaluation of periodic limb movements in a putative animal model of restless leg syndrome. | Movement disorders : official journal of the Movement Disorder Society 20120301 |
| The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. | Neuroscience research 20120301 |
| Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner. | Molecular medicine reports 20120301 |
| Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-κB in SH-SY5Y cells. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120301 |
| IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells. | European journal of pharmacology 20120227 |
| Frequency selectivity and dopamine-dependence of plasticity at glutamatergic synapses in the subthalamic nucleus. | Neuroscience 20120217 |
| Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions. | Brain research bulletin 20120210 |
| Mild dopaminergic lesions are accompanied by robust changes in subthalamic nucleus activity. | Neuroscience letters 20120206 |
| Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. | Neurobiology of aging 20120201 |
| The glutamatergic component of the mesocortical pathway emanating from different subregions of the ventral midbrain. | Cerebral cortex (New York, N.Y. : 1991) 20120201 |
| Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease. | Neurotoxicity research 20120201 |
| Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats. | Neurotoxicity research 20120201 |
| Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny. | Neurotoxicity research 20120201 |
| In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET. | NeuroImage 20120201 |
| AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth. | Molecular therapy : the journal of the American Society of Gene Therapy 20120201 |
| Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats. | Neuropharmacology 20120201 |
| The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. | The Journal of pharmacology and experimental therapeutics 20120201 |
| Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: a self-perpetuating crosstalk? | Biochimica et biophysica acta 20120201 |
| Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. | Nature neuroscience 20120201 |
| Striatal dopamine depletion in rats produces variable effects on contingency detection: task-related influences. | The European journal of neuroscience 20120201 |
| Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism. | Neuroscience 20120127 |
| The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle. | Neuroscience 20120127 |
| RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. | Neuron 20120126 |
| Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats. | ACS chemical neuroscience 20120118 |
| Automated gait analysis in bilateral parkinsonian rats and the role of L-DOPA therapy. | Behavioural brain research 20120115 |
| Lesions of the dopaminergic innervation of the nucleus accumbens medial shell delay the generation of preference for sucrose, but not of sexual pheromones. | Behavioural brain research 20120115 |
| Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action. | Neuroscience letters 20120111 |
| Unchanged expression of the ceramide transfer protein in the acute 6-OHDA neurodegenerative model. | Neuroscience letters 20120106 |
| The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias. | Brain research bulletin 20120104 |
| Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. | Neurobiology of aging 20120101 |
| Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease. | Current stem cell research & therapy 20120101 |
| Changes in the mRNA levels of α2A and α2C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesia. | Journal of molecular neuroscience : MN 20120101 |
| Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology. | Cell transplantation 20120101 |
| Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease. | Journal of molecular neuroscience : MN 20120101 |
| Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. | Cellular and molecular neurobiology 20120101 |
| Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum. | Journal of molecular neuroscience : MN 20120101 |
| A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission. | Experimental neurology 20120101 |
| Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia. | Behavioural brain research 20120101 |
| Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats. | Pharmacology, biochemistry, and behavior 20120101 |
| Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease. | Neurotoxicity research 20120101 |
| Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model. | Experimental neurology 20120101 |
| Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model. | Neurobiology of disease 20120101 |
| Animal models of Parkinson's disease. | Parkinsonism & related disorders 20120101 |
| Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system. | Brain : a journal of neurology 20120101 |
| Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat. | The European journal of neuroscience 20120101 |
| ADHD animal model characterization: transcriptomics and proteomics analyses. | Methods in molecular biology (Clifton, N.J.) 20120101 |
| Reduced proliferation in the adult mouse subventricular zone increases survival of olfactory bulb interneurons. | PloS one 20120101 |
| Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for neuroprotective assays relevant to Parkinson's disease. | Methods in molecular biology (Clifton, N.J.) 20120101 |
| A 6-hydroxydopamine in vivo model of Parkinson's disease. | Methods in molecular biology (Clifton, N.J.) 20120101 |
| Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease. | Journal of visualized experiments : JoVE 20120101 |
| Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat. | PloS one 20120101 |
| Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons. | Bioscience, biotechnology, and biochemistry 20120101 |
| Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. | BMC neuroscience 20120101 |
| Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease. | PloS one 20120101 |
| Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model. | Journal of pharmacological sciences 20120101 |
| Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys. | PloS one 20120101 |
| Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo. | PloS one 20120101 |
| The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats. | PloS one 20120101 |
| Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death. | PloS one 20120101 |
| Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian rats. | Biological & pharmaceutical bulletin 20120101 |
| Inhibition of the acquisition of conditioned place aversion by dopaminergic lesions of the central nucleus of the amygdala in morphine-treated rats. | Physiological research 20120101 |
| Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia. | Pharmacological reports : PR 20120101 |
| Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line. | International journal of molecular sciences 20120101 |
| Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells. | PloS one 20120101 |
| Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway. | Neuroscience 20111229 |
| Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia. | Neuroscience 20111215 |
| Motor disorders and impaired electrical power of pallidal EEG improved by gallic acid in animal model of Parkinson's disease. | Pakistan journal of biological sciences : PJBS 20111215 |
| Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia. | Journal of neural transmission (Vienna, Austria : 1996) 20111201 |
| Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats. | Journal of neural transmission (Vienna, Austria : 1996) 20111201 |
| Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20111201 |
| Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing. | Journal of psychopharmacology (Oxford, England) 20111201 |
| Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20111201 |
| Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model. | Neurochemical research 20111201 |
| Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway. | Neuropharmacology 20111201 |
| Tacrine(2)-ferulic acid, a novel multifunctional dimer, attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by activating Akt pathway. | Neurochemistry international 20111201 |
| Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. | Experimental neurology 20111201 |
| Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation. | Experimental neurology 20111201 |
| Regeneration of dopaminergic neurons after 6-hydroxydopamine-induced lesion in planarian brain. | Journal of neurochemistry 20111201 |
| Effect of DHEA on recovery of muscle atrophy induced by Parkinson's disease. | Journal of Korean Academy of Nursing 20111201 |
| The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model. | Brain research bulletin 20111125 |
| Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms. | Neuroscience 20111124 |
| Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease. | Behavioural brain research 20111120 |
| Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice. | Journal of neuroscience methods 20111115 |
| Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats. | Biological psychiatry 20111115 |
| A quantitative comparison of basal ganglia neuronal activities of normal and Parkinson's disease model rats. | Neuroscience letters 20111114 |
| Induction of dopaminergic neuronal-like cells from CD44+ human amniotic fluids that are ameliorative to behavioral recovery in a Parkinson's disease rat model. | International journal of molecular medicine 20111101 |
| Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration. | Apoptosis : an international journal on programmed cell death 20111101 |
| Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease. | Toxicology and applied pharmacology 20111101 |
| c-Fos expression after deep brain stimulation of the pedunculopontine tegmental nucleus in the rat 6-hydroxydopamine Parkinson model. | Journal of chemical neuroanatomy 20111101 |
| Overhauser-enhanced magnetic resonance imaging characterization of mitochondria functional changes in the 6-hydroxydopamine rat model. | Neurochemistry international 20111101 |
| Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death. | Journal of neural transmission (Vienna, Austria : 1996) 20111101 |
| Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion. | Hormones and behavior 20111101 |
| The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats. | Brain : a journal of neurology 20111101 |
| [Neonatal lesions of catecholaminergic system prevents maturation of cholinergic innervation of the rat neocortex]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20111101 |
| Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats. | Neuroscience letters 20111031 |
| Blockade of mGluR5 reverses abnormal firing of subthalamic nucleus neurons in 6-hydroxydopamine partially lesioned rats. | The Chinese journal of physiology 20111031 |
| Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease. | Brain research 20111028 |
| Modulation of the activity of globus pallidus by dopamine D1-like receptors in parkinsonian rats. | Neuroscience 20111027 |
| Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. | Human molecular genetics 20111015 |
| Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism. | Neuroscience 20111013 |
| An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats. | Fundamental & clinical pharmacology 20111001 |
| Neuroprotection by estradiol: some important considerations. | Human & experimental toxicology 20111001 |
| 17β-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2. | Journal of molecular neuroscience : MN 20111001 |
| Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain. | Journal of molecular neuroscience : MN 20111001 |
| Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats. | Pharmacology, biochemistry, and behavior 20111001 |
| Effects of dopamine depletion on information flow between the subthalamic nucleus and external globus pallidus. | Journal of neurophysiology 20111001 |
| Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease. | Behavioural pharmacology 20111001 |
| The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death. | The European journal of neuroscience 20111001 |
| Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments. | Bulletin of experimental biology and medicine 20111001 |
| Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease. | Behavioural brain research 20110930 |
| Posterior hypothalamic nucleus deep brain stimulation restores locomotion in rats with haloperidol-induced akinesia but not skilled forelimb use in pellet reaching and lever pressing. | Neuroscience 20110929 |
| Lesions of the ventral ascending noradrenergic bundles decrease the stress response to occlusal disharmony in rats. | Neuroscience letters 20110926 |
| Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain. | Brain research 20110926 |
| Tongue force and timing deficits in a rat model of Parkinson disease. | Behavioural brain research 20110923 |
| Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease. | Biochemical and biophysical research communications 20110923 |
| Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats. | Neuroscience letters 20110915 |
| Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion. | Behavioural brain research 20110912 |
| Noradrenergic projections to the ventromedial hypothalamus regulate fat metabolism during endurance exercise. | Neuroscience 20110908 |
| In vivo effect of 5-HT₇ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study. | Neuroscience 20110908 |
| Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. | Neuron 20110908 |
| Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. | Nature neuroscience 20110904 |
| Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia. | Neurobiology of disease 20110901 |
| Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. | Neurobiology of disease 20110901 |
| Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease. | Neuroscience research 20110901 |
| Noradrenergic regulation of itch transmission in the spinal cord mediated by α-adrenoceptors. | Neuropharmacology 20110901 |
| Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors. | The Journal of pharmacology and experimental therapeutics 20110901 |
| High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats. | Experimental neurology 20110901 |
| Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease. | Neurobiology of disease 20110901 |
| GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease. | Neuroscience research 20110901 |
| Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Journal of ethnopharmacology 20110901 |
| Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease. | Journal of neuropathology and experimental neurology 20110901 |
| Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110831 |
| Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates. | Journal of neuroscience methods 20110830 |
| [High-frequency electro-acupuncture stimulation modulates intracerebral γ-aminobutyric acid content in rat model of Parkinson's disease]. | Sheng li xue bao : [Acta physiologica Sinica] 20110825 |
| [Effects and mechanism of low frequency stimulation of pedunculopontine nucleus on spontaneous discharges of ventrolateral thalamic nucleus in rats]. | Sheng li xue bao : [Acta physiologica Sinica] 20110825 |
| Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20110815 |
| Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum. | Neuroscience letters 20110815 |
| Blood pressure increased dramatically in hypertensive rats after left hemisphere lesions with 6-hydroxydopamine. | Neuroscience letters 20110815 |
| Protective potential of 17β-estradiol against co-exposure of 4-hydroxynonenal and 6-hydroxydopamine in PC12 cells. | Human & experimental toxicology 20110801 |
| Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease. | British journal of pharmacology 20110801 |
| Mortalin inhibition in experimental Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20110801 |
| Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et al. | Experimental neurology 20110801 |
| Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. | Journal of neurochemistry 20110801 |
| Endogenous morphine-like compound immunoreactivity increases in parkinsonism. | Brain : a journal of neurology 20110801 |
| Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425. | Nuclear medicine and biology 20110801 |
| Alterations in brain connectivity underlying beta oscillations in Parkinsonism. | PLoS computational biology 20110801 |
| 6-Hydroxydopamine lesions of the ventral tegmental area suppress ghrelin's ability to elicit food-reinforced behavior. | Neuroscience letters 20110720 |
| Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats. | Brain research bulletin 20110715 |
| Overexpression of Nrdp1/FLRF sensitizes cells to oxidative stress. | Biochemical and biophysical research communications 20110715 |
| Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile. | Journal of medicinal chemistry 20110714 |
| Cortical stimulation evokes abnormal responses in the dopamine-depleted rat basal ganglia. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110713 |
| Trophic and immunoregulatory properties of neural precursor cells: benefit for intracerebral transplantation. | Experimental neurology 20110701 |
| Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells. | Neurochemistry international 20110701 |
| Progressive impairment in motor skill learning at 12 and 20 weeks post 6-OHDA- SNc lesion in rats. | Parkinsonism & related disorders 20110701 |
| Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA. | Molecular and cellular biochemistry 20110701 |
| PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology. | Neurobiology of disease 20110701 |
| Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia. | Journal of neurochemistry 20110701 |
| Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's. | Nuclear medicine and biology 20110701 |
| Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury. | Neuroscience letters 20110622 |
| Three-dimensional motion analysis of postural adjustments during over-ground locomotion in a rat model of Parkinson's disease. | Behavioural brain research 20110620 |
| Dynamic changes of striatal dopamine D2 receptor binding at later stages after unilateral lesions of the medial forebrain bundle in Parkinsonian rat models. | Neuroscience letters 20110608 |
| Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats. | Cerebellum (London, England) 20110601 |
| Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. | Neurobiology of disease 20110601 |
| The influence of autonomic interventions on the sleep-wake-related changes in gastric myoelectrical activity in rats. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20110601 |
| Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease. | Neurochemical research 20110601 |
| Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. | Experimental neurology 20110601 |
| Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat. | The Journal of pharmacology and experimental therapeutics 20110601 |
| The effect of catecholaminergic depletion within the prelimbic and infralimbic medial prefrontal cortex on recognition memory for recency, location, and objects. | Behavioral neuroscience 20110601 |
| Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats. | The European journal of neuroscience 20110601 |
| Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease. | Neuroscience letters 20110527 |
| Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine. | Neurotoxicity research 20110501 |
| Nestin (+) stem cells independently contribute to neural remodelling of the ischemic heart. | Journal of cellular physiology 20110501 |
| Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion. | Journal of cellular physiology 20110501 |
| Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. | Molecular therapy : the journal of the American Society of Gene Therapy 20110501 |
| Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats. | Neuropharmacology 20110501 |
| Detoxification of 6-hydroxydopamine-induced Parkinsonian neurodegeneration by G-CYPMPO, a novel radical trapper. | Neurochemistry international 20110501 |
| Restoration of motor control and dopaminergic activity in rats with unilateral 6-hydroxy-dopamine lesions. | Regenerative medicine 20110501 |
| Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons. | The Chinese journal of physiology 20110430 |
| Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells. | Brain research 20110428 |
| Reduction of an afterhyperpolarization current increases excitability in striatal cholinergic interneurons in rat parkinsonism. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110427 |
| Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD). | Neuroscience letters 20110420 |
| The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease. | Brain research 20110412 |
| Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors. | Neurobiology of aging 20110401 |
| Noise benefit in prepulse inhibition of the acoustic startle reflex. | Psychopharmacology 20110401 |
| Necdin and neurotrophin receptors: interactors of relevance for neuronal resistance to oxidant stress. | Pediatric research 20110401 |
| Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110401 |
| Context-driven changes in L-DOPA-induced behaviours in the 6-OHDA lesioned rat. | Neurobiology of disease 20110401 |
| In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model. | The European journal of neuroscience 20110401 |
| Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models. | Journal of ethnopharmacology 20110324 |
| Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110323 |
| Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. | Brain research 20110310 |
| LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. | Cell stem cell 20110304 |
| Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease. | The international journal of neuropsychopharmacology 20110301 |
| Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease? | Antioxidants & redox signaling 20110301 |
| Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. | Psychopharmacology 20110301 |
| Phosphorylation of p66shc mediates 6-hydroxydopamine cytotoxicity. | Free radical research 20110301 |
| BN82451 attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. | Neuropharmacology 20110301 |
| Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition. | Pharmacology, biochemistry, and behavior 20110301 |
| Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease. | Free radical biology & medicine 20110301 |
| Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. | Experimental neurology 20110301 |
| Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease. | Neurochemical research 20110301 |
| In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression. | Neurochemistry international 20110301 |
| C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase Cϵ/Nrf2 pathway. | Journal of neuroscience research 20110301 |
| [Effects and mechanism of Plastrum testudinis extracts on PC12 apoptosis]. | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20110301 |
| Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions. | Brain research bulletin 20110227 |
| Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat. | Neuroscience 20110223 |
| Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110216 |
| Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis. | Neuroscience letters 20110211 |
| Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110209 |
| Lever pressing responses under a fixed-ratio schedule of mice with 6-hydroxydopamine-induced dopamine depletion in the nucleus accumbens. | Behavioural brain research 20110202 |
| The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110202 |
| Identification of nigral dopaminergic neuron-enriched genes in adult rats. | Neurobiology of aging 20110201 |
| Possible regulatory factors for intra-abdominal fat mass in a rat model of Parkinson's disease. | Nutrition (Burbank, Los Angeles County, Calif.) 20110201 |
| Minor retinal degeneration in Parkinson's disease. | Medical hypotheses 20110201 |
| Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease. | Neurobiology of disease 20110201 |
| The hydrolysis of striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease. | Neurochemical research 20110201 |
| 6-Hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation. | Neurochemical research 20110201 |
| Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. | International journal of molecular medicine 20110201 |
| Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat. | Neurochemistry international 20110201 |
| Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats. | Brain research bulletin 20110201 |
| Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. | Brain : a journal of neurology 20110201 |
| Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. | Rejuvenation research 20110201 |
| Mesencephalic astrocyte-derived neurotrophic factor (MANF) has a unique mechanism to rescue apoptotic neurons. | The Journal of biological chemistry 20110128 |
| Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease. | Journal of ethnopharmacology 20110127 |
| Dangguijakyak-san, a medicinal herbal formula, protects dopaminergic neurons from 6-hydroxydopamine-induced neurotoxicity. | Journal of ethnopharmacology 20110127 |
| The role of dopamine in the dorsomedial striatum in place and response learning. | Neuroscience 20110113 |
| Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease. | Brain research 20110107 |
| Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110105 |
| Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease. | Molecular therapy : the journal of the American Society of Gene Therapy 20110104 |
| Knockdown of glycogen synthase kinase 3 beta attenuates 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells. | Neuroscience letters 20110103 |
| Development of bladder dysfunction in a rat model of dopaminergic brain lesion. | Neurourology and urodynamics 20110101 |
| Striatal dopaminergic fiber recovery after acute L-DOPA treatment in 6-hydroxydopamine (6-OHDA) lesioned rats. | Cell biochemistry and biophysics 20110101 |
| L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata. | Neurobiology of disease 20110101 |
| Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy. | Neurotoxicology and teratology 20110101 |
| Endoplasmic reticulum stress inducers provide protection against 6-hydroxydopamine-induced cytotoxicity. | Neurochemistry international 20110101 |
| HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. | Nature neuroscience 20110101 |
| Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation. | Journal of biomedical science 20110101 |
| CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. | Journal of neuroinflammation 20110101 |
| In vivo imaging neurotransmitter function. The rat 6-hydroxydopamine model and its relevance for human Parkinson's disease. | Nuklearmedizin. Nuclear medicine 20110101 |
| Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism. | Neuro-degenerative diseases 20110101 |
| Catecholaminergic depletion in nucleus accumbens enhances trace conditioning. | Advances in medical sciences 20110101 |
| Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses. | PloS one 20110101 |
| Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats. | Neoplasma 20110101 |
| Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. | PloS one 20110101 |
| [Comparative study of amantadine and hemantane effects on development of levodopa-induced dyskinesia in rat model of parkinsonian syndrome]. | Eksperimental'naia i klinicheskaia farmakologiia 20110101 |
| MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model. | PloS one 20110101 |
| Chopper is prodeath regardless of the effect of p75ICD on sensitivity to oxidative stress. | Oxidative medicine and cellular longevity 20110101 |
| Clinical and experimental experiences of graft-induced dyskinesia. | International review of neurobiology 20110101 |
| Modeling dopamine neuron degeneration in Caenorhabditis elegans. | Methods in molecular biology (Clifton, N.J.) 20110101 |
| Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway. | PloS one 20110101 |
| Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats. | Pharmacological reports : PR 20110101 |
| Identification of bilateral changes in TID1 expression in the 6-OHDA rat model of Parkinson's disease. | PloS one 20110101 |
| Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study. | PloS one 20110101 |
| Excessive expression of hippocampal ezrin is induced by intrastriatal injection of 6-hydroxydopamine. | Biological & pharmaceutical bulletin 20110101 |
| Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. | Journal of pharmacological sciences 20110101 |
| Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases. | PloS one 20110101 |
| CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. | Journal of neuroinflammation 20110101 |
| Pharmacological challenge and synaptic response - assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET). | Reviews in the neurosciences 20110101 |
| Oxidation of DJ-1 induced by 6-hydroxydopamine decreasing intracellular glutathione. | PloS one 20110101 |
| Mildronate as a regulator of protein expression in a rat model of Parkinson's disease. | Medicina (Kaunas, Lithuania) 20110101 |
| Partial lesion of the dopaminergic innervation of the ventral striatum induces 'depressive-like' behavior of rats. | Pharmacological reports : PR 20110101 |
| p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission. | Behavioural brain research 20101225 |
| Long term exposure to norharman exacerbates 6-hydroxydopamine-induced parkinsonism: possible involvement of L-type Ca2+ channels. | Behavioural brain research 20101220 |
| Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease. | Neuroscience letters 20101217 |
| Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells. | Journal of cellular biochemistry 20101215 |
| An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20101208 |
| Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease. | Neuroscience letters 20101203 |
| Creating a ventral midbrain stem cell niche in an animal model for Parkinson's disease. | Stem cells and development 20101201 |
| Lateralized response of oxytocinase activity in the medial prefrontal cortex of a unilateral rat model of Parkinson's disease. | Behavioural brain research 20101201 |
| Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease. | Basic & clinical pharmacology & toxicology 20101201 |
| Early toxic effect of 6-hydroxydopamine on extracellular concentrations of neurotransmitters in the rat striatum: an in vivo microdialysis study. | Neurotoxicology 20101201 |
| The dopamine transporter is differentially regulated after dopaminergic lesion. | Neurobiology of disease 20101201 |
| Effects of simvastatin and 6-hydroxydopamine on histaminergic H1 receptor binding density in rat brains. | Progress in neuro-psychopharmacology & biological psychiatry 20101201 |
| Neurocytoprotective effects of the bioactive constituents of Pueraria thomsonii in 6-hydroxydopamine (6-OHDA)-treated nerve growth factor (NGF)-differentiated PC12 cells. | Phytochemistry 20101201 |
| Biomarkers of cell damage induced by oxidative stress in Parkinson's disease and related models. | Central nervous system agents in medicinal chemistry 20101201 |
| Efficient regeneration by activation of neurogenesis in homeostatically quiescent regions of the adult vertebrate brain. | Development (Cambridge, England) 20101201 |
| Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place. | Behavioral neuroscience 20101201 |
| [Autophagy is involved in 6-OHDA-induced dopaminergic cell death]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20101201 |
| Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat. | Behavioural brain research 20101112 |
| Droplet microfluidics for characterizing the neurotoxin-induced responses in individual Caenorhabditis elegans. | Lab on a chip 20101107 |
| Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101 |
| Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain. | Brain, behavior, and immunity 20101101 |
| Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum. | Neurochemistry international 20101101 |
| The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra. | Glia 20101101 |
| Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats. | Neurochemistry international 20101101 |
| Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation. | Neurochemistry international 20101101 |
| Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats. | Experimental neurology 20101101 |
| α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease. | Molecular pharmacology 20101101 |
| Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. | Annals of neurology 20101101 |
| Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death. | Journal of neuropathology and experimental neurology 20101101 |
| Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes. | Cell and tissue research 20101101 |
| Challenges facing quantification of rat locomotion along beams of varying widths. | Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine 20101101 |
| Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20101020 |
| Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20101020 |
| Graft-mediated functional recovery on a skilled forelimb use paradigm in a rodent model of Parkinson's disease is dependent on reward contingency. | Behavioural brain research 20101015 |
| Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals. | Neuroscience letters 20101015 |
| Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. | Cerebral cortex (New York, N.Y. : 1991) 20101001 |
| Effects of zona incerta lesions on striatal neurochemistry and behavioral asymmetry in 6-hydroxydopamine-lesioned rats. | Journal of neuroscience research 20101001 |
| Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease. | Neurochemistry international 20101001 |
| Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease. | Neurochemical research 20101001 |
| Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion. | Pharmacology, biochemistry, and behavior 20101001 |
| Dose-response relationship between norepinephrine and erythropoiesis: evidence for a critical threshold. | The Journal of surgical research 20101001 |
| Proteasome inhibition in medaka brain induces the features of Parkinson's disease. | Journal of neurochemistry 20101001 |
| Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet. | American journal of physiology. Regulatory, integrative and comparative physiology 20101001 |
| Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat. | Behavioural pharmacology 20101001 |
| Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson's disease. | Neuroscience bulletin 20101001 |
| Chemical or surgical sympathectomy prevents mechanical hyperalgesia induced by intraplantar injection of bee venom in rats. | Brain research 20100924 |
| Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro. | Journal of neuroimmunology 20100914 |
| Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes. | Journal of proteome research 20100903 |
| Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats. | Journal of neurosurgery 20100901 |
| A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. | Neurobiology of disease 20100901 |
| In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats. | Neuroscience 20100901 |
| The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra. | Journal of neurochemistry 20100901 |
| Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease. | European journal of medicinal chemistry 20100901 |
| Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. | British journal of pharmacology 20100901 |
| A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death. | Neuroscience letters 20100830 |
| Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Age-specific effects of 6-hydroxydopamine lesions of the rat medial prefrontal cortex on stress-induced c-fos expression in subcortical areas. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20100815 |
| Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment. | Movement disorders : official journal of the Movement Disorder Society 20100815 |
| The different performance among motor tasks during the increasing current intensity of deep brain stimulation of the subthalamic nucleus in rats with different degrees of the unilateral striatal lesion. | Neuroscience letters 20100809 |
| [Relationship of oxidative DNA damage and expression of mitochondrial apoptotic proteins in rat striatum induced by 6-hydroxydopamine]. | Zhonghua yi xue za zhi 20100803 |
| Decreased RGS9 protein level in the striatum of rodents undergoing MPTP or 6-OHDA neurotoxicity. | Neuroscience letters 20100802 |
| The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model. | Cellular and molecular neurobiology 20100801 |
| Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model. | Neurochemistry international 20100801 |
| An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100801 |
| Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression. | Experimental neurology 20100801 |
| A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. | Parkinsonism & related disorders 20100801 |
| Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease. | Experimental neurology 20100801 |
| Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in adolescent and adult rats. | Brain research 20100730 |
| Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism. | Brain research bulletin 20100730 |
| Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study. | Brain research 20100730 |
| Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. | Behavioural brain research 20100729 |
| Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. | Nature 20100729 |
| Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20100721 |
| Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism. | Brain research 20100716 |
| Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. | Stem cells and development 20100701 |
| Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models. | The British journal of nutrition 20100701 |
| Neuroectodermally converted human mesenchymal stromal cells provide cytoprotective effects on neural stem cells and inhibit their glial differentiation. | Cytotherapy 20100701 |
| Disconnection of the entorhinal cortex and dorsomedial striatum impairs the sensitivity to instrumental contingency degradation. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100701 |
| Lack of effect of dopaminergic denervation on caudate-putamen hyperthermia or hypothermia induced by drugs and mild stressors. | Pharmacology, biochemistry, and behavior 20100701 |
| Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease. | Journal of neurochemistry 20100701 |
| Sympathetic modulation of the host defense response to infectious challenge during recovery from hemorrhage. | Neuroimmunomodulation 20100701 |
| Cocaine reverses the changes in GABAA subunits and in glutamic acid decarboxylase isoenzymes mRNA expression induced by neonatal 6-hydroxydopamine. | Behavioural pharmacology 20100701 |
| Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling. | Acta pharmacologica Sinica 20100701 |
| GPI-1046 increases presenilin-1 expression and restores NMDA channel activity. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20100701 |
| Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism. | Neuroscience 20100630 |
| Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model. | Behavioural brain research 20100626 |
| Locomotion analysis of Sprague-Dawley rats before and after injecting 6-OHDA. | Behavioural brain research 20100626 |
| Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. | Brain research 20100614 |
| Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. | Brain research 20100608 |
| L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. | Neurobiology of aging 20100601 |
| Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. | The Journal of nutritional biochemistry 20100601 |
| Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells. | Journal of molecular neuroscience : MN 20100601 |
| MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism. | Neuropharmacology 20100601 |
| Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye. | Acta physiologica (Oxford, England) 20100601 |
| Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). | Peptides 20100601 |
| Pre-synaptic glutamate-induced activation of DA release in the striatum after partial nigral lesion. | Journal of neurochemistry 20100601 |
| Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule. | Free radical research 20100601 |
| Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. | Journal of neurochemistry 20100601 |
| On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079. | Journal of neural transmission (Vienna, Austria : 1996) 20100601 |
| Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease. | The International journal of neuroscience 20100601 |
| Protective effect of Cyperi rhizoma against 6-hydroxydopamine-induced neuronal damage. | Journal of medicinal food 20100601 |
| Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. | The European journal of neuroscience 20100601 |
| [Biochemical changes in striatum of Parkinson's disease rat model observed by modified proton magnetic resonance spectroscopy]. | Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20100601 |
| Acquisition and performance in a rat sequential reaction time task is not affected by subtotal ventral striatal 6-OHDA lesions. | Neuroscience letters 20100526 |
| Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20100526 |
| High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease. | Journal of neuroscience research 20100515 |
| Behavioral and electrophysiological effects of 5-HT in globus pallidus of 6-hydroxydopamine lesioned rats. | Journal of neuroscience research 20100515 |
| Action of 6-amino-3-pyridinols as novel antioxidants against free radicals and oxidative stress in solution, plasma, and cultured cells. | Free radical biology & medicine 20100515 |
| Dopamine D1 receptor gene expression studies in unilateral 6-hydroxydopamine-lesioned Parkinson's rat: effect of 5-HT, GABA, and bone marrow cell supplementation. | Journal of molecular neuroscience : MN 20100501 |
| Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease. | Neurochemical research 20100501 |
| Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo. | Journal of neural transmission (Vienna, Austria : 1996) 20100501 |
| The Galectin-1 level in serum as a novel marker for stress. | Glycoconjugate journal 20100501 |
| Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease. | Behavioural pharmacology 20100501 |
| [Disruption of latent inhibition in adult rats after prepubertal dopamine terminals lesions in the ventral hippocampus]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20100501 |
| Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. | Brain research 20100430 |
| Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease. | Brain research bulletin 20100429 |
| Alterations of Hrd1 expression in various encephalic regional neurons in 6-OHDA model of Parkinson's disease. | Neuroscience letters 20100426 |
| Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. | Science translational medicine 20100421 |
| Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Molecules (Basel, Switzerland) 20100416 |
| Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease. | Brain research 20100409 |
| Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats. | Brain research 20100409 |
| Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat. | Brain research bulletin 20100405 |
| The role of dopamine in the prelimbic cortex and the dorsomedial striatum in instrumental conditioning. | Cerebral cortex (New York, N.Y. : 1991) 20100401 |
| Acute L: -DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of parkinsonian rats. | Neurotoxicity research 20100401 |
| In vivo but not in vitro leptin enhances lymphocyte proliferation in Siberian hamsters (Phodopus sungorus). | General and comparative endocrinology 20100401 |
| Torpor and ultradian rhythms require an intact signalling of the sympathetic nervous system. | Cryobiology 20100401 |
| Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease. | Neurochemical research 20100401 |
| Protective effects of standardized Thuja orientalis leaves against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. | Toxicology in vitro : an international journal published in association with BIBRA 20100401 |
| Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. | Aging cell 20100401 |
| 6-hydroxydopamine lesions in the rat neostriatum impair sequential learning in a serial reaction time task. | Neurotoxicity research 20100401 |
| Metallocorroles as cytoprotective agents against oxidative and nitrative stress in cellular models of neurodegeneration. | Journal of neurochemistry 20100401 |
| Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease. | Neurobiology of disease 20100401 |
| Proteomic characterization of the striatum and midbrain treated with 6-hydroxydopamine: alteration of 58-kDa glucose-regulated protein and C/EBP homologous protein. | Free radical research 20100401 |
| Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI. | Magma (New York, N.Y.) 20100401 |
| Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease. | Biochemical and biophysical research communications 20100319 |
| Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinson's disease. | Behavioural brain research 20100317 |
| Site-specific action of L-3,4-dihydroxyphenylalanine in the striatum but not globus pallidus and substantia nigra pars reticulata evokes dyskinetic movements in chronic L-3,4-dihydroxyphenylalanine-treated 6-hydroxydopamine-lesioned rats. | Neuroscience 20100317 |
| Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures. | Experimental cell research 20100310 |
| The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease. | Neuroreport 20100310 |
| Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats. | Cell stem cell 20100305 |
| Different striatal D2-like receptor function in an early stage after unilateral striatal lesion and medial forebrain bundle lesion in rats. | Brain research 20100304 |
| Positron emission tomography kinetic modeling algorithms for small animal dopaminergic system imaging. | Synapse (New York, N.Y.) 20100301 |
| Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats. | Synapse (New York, N.Y.) 20100301 |
| Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease. | The Journal of pharmacology and experimental therapeutics 20100301 |
| Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease. | Neuroscience research 20100301 |
| A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. | Neuropharmacology 20100301 |
| L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia. | Journal of neurochemistry 20100301 |
| Involvement of induction and mitochondrial targeting of orphan nuclear receptor Nur77 in 6-OHDA-induced SH-SY5Y cell death. | Neurochemistry international 20100301 |
| Role of locus coeruleus noradrenergic neurons in cardiorespiratory and thermal control during hypoxia. | Respiratory physiology & neurobiology 20100227 |
| In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease. | Brain research 20100226 |
| High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20100210 |
| 6-hydroxydopamine lesions enhance progesterone-facilitated lordosis of rats and hamsters, independent of effects on motor behavior. | Physiology & behavior 20100209 |
| The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond. | Progress in neurobiology 20100209 |
| Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate. | Brain research 20100202 |
| Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat. | Brain research 20100202 |
| The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats. | Neuropharmacology 20100201 |
| The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. | Synapse (New York, N.Y.) 20100201 |
| Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease. | Free radical biology & medicine 20100201 |
| The role of nucleus accumbens dopamine in outcome encoding in instrumental and Pavlovian conditioning. | Neurobiology of learning and memory 20100201 |
| Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. | Experimental neurology 20100201 |
| Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells. | Neurochemistry international 20100201 |
| Neuroprotective effects of zonisamide target astrocyte. | Annals of neurology 20100201 |
| A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine. | Neuroscience letters 20100129 |
| Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20100120 |
| Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease. | Brain research 20100115 |
| Exercise exerts neuroprotective effects on Parkinson's disease model of rats. | Brain research 20100115 |
| Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease. | Free radical biology & medicine 20100115 |
| Cortical oscillations scan using chirp-evoked potentials in 6-hydroxydopamine rat model of Parkinson's disease. | Brain research 20100115 |
| Activation of the NMDA receptor involved in the alleviating after-effect of repeated stimulation of the subthalamic nucleus on motor deficits in hemiparkinsonian rats. | Brain research 20100108 |
| Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways. | Journal of ethnopharmacology 20100108 |
| The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells. | Neuroscience letters 20100104 |
| Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. | Toxicology and applied pharmacology 20100101 |
| Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. | Neurochemistry international 20100101 |
| D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. | Pharmacology, biochemistry, and behavior 20100101 |
| Expression of tyrosine hydroxylase increases the resistance of human neuroblastoma cells to oxidative insults. | Toxicological sciences : an official journal of the Society of Toxicology 20100101 |
| The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats. | Journal of neurochemistry 20100101 |
| Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. | Cell transplantation 20100101 |
| L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation. | Neurochemistry international 20100101 |
| Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors. | Experimental neurology 20100101 |
| Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test. | Journal of visualized experiments : JoVE 20100101 |
| Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson's disease. | Journal of biomedical science 20100101 |
| Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine. | PloS one 20100101 |
| Dopamine neuron stimulating actions of a GDNF propeptide. | PloS one 20100101 |
| Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study. | Chronobiology international 20100101 |
| Lactotroph functional activity in hypothalamic dopaminergic system insufficiency. | Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20100101 |
| Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons. | Biochimica et biophysica acta 20100101 |
| Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. | BMC neuroscience 20100101 |
| A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease. | Journal of communication disorders 20100101 |
| Animal models of neurological disease. | Advances in experimental medicine and biology 20100101 |
| Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20100101 |
| Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats. | Pharmacological reports : PR 20100101 |
| Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide. | Redox report : communications in free radical research 20100101 |
| 6-hydroxydopamine-mediated release of norepinephrine increases faecal excretion of Salmonella enterica serovar Typhimurium in pigs. | Veterinary research 20100101 |
| Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats. | Pharmacology 20100101 |
| Automated quantitative gait analysis in animal models of movement disorders. | BMC neuroscience 20100101 |
| Effects of GPi and STN inactivation on physiological, motor, cognitive and motivational processes in animal models of Parkinson's disease. | Progress in brain research 20100101 |
| Neurotoxic in vivo models of Parkinson's disease recent advances. | Progress in brain research 20100101 |
| Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson's disease. | Progress in brain research 20100101 |
| Modeling neuroinflammatory pathogenesis of Parkinson's disease. | Progress in brain research 20100101 |
| Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease. | International journal of molecular sciences 20100101 |
| Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats. | PloS one 20100101 |
| The effect of chemical sympathectomy and stress on bone remodeling in adult rats. | Neuro endocrinology letters 20100101 |
| Modulation of excessive neuronal activity by fibroblasts: potential use in treatment of Parkinson's disease. | Restorative neurology and neuroscience 20100101 |
| Effects of low doses of intracerebroventricular 6-OHDA on the levels of monoaminergic neurotransmitters in rat brain structures. | Pharmacological reports : PR 20100101 |
| Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease. | Neuroscience letters 20091231 |
| The dual dopamine-glutamate phenotype of growing mesencephalic neurons regresses in mature rat brain. | The Journal of comparative neurology 20091220 |
| Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection. | Brain research bulletin 20091216 |
| Necdin and TrkA contribute to modulation by p75NTR of resistance to oxidant stress. | Experimental cell research 20091210 |
| Effect of intranigral injection of GDNF and EGF on the survival and possible differentiation fate of progenitors and immature neurons in 6-OHDA-lesioned rats. | Neurochemical research 20091201 |
| Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus. | Neuroscience 20091201 |
| Dopamine D(2)-class receptor supersensitivity as reflected in Ca2+ current modulation in neostriatal neurons. | Neuroscience 20091201 |
| The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway. | Neuroscience 20091201 |
| C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1. | Experimental neurology 20091201 |
| The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism. | Journal of leukocyte biology 20091201 |
| Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury. | Pain 20091201 |
| Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. | Journal of neurochemistry 20091201 |
| Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis. | Diabetologia 20091201 |
| Effect of exercise on dopamine neuron survival in prenatally stressed rats. | Metabolic brain disease 20091201 |
| Biochemical alteration in cerebrospinal fluid precedes behavioral deficits in Parkinsonian rats induced by 6-hydroxydopamine. | Surgical neurology 20091201 |
| Editorial: regulation of the regulator: sympathetic nervous system control of regulatory T cells. | Journal of leukocyte biology 20091201 |
| Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. | Parkinsonism & related disorders 20091201 |
| Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease. | Journal of ethnopharmacology 20091112 |
| Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats. | Neuroscience 20091110 |
| The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease. | Behavioural brain research 20091105 |
| Cruciferous nutraceutical 3H-1,2-dithiole-3-thione protects human primary astrocytes against neurocytotoxicity elicited by MPTP, MPP(+), 6-OHDA, HNE and acrolein. | Neurochemical research 20091101 |
| Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. | Neurochemistry international 20091101 |
| Reward-seeking and discrimination deficits displayed by hypodopaminergic mice are prevented in mice lacking dopamine D4 receptors. | Synapse (New York, N.Y.) 20091101 |
| Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20091101 |
| Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism. | Experimental neurology 20091101 |
| Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents. | Journal of pineal research 20091101 |
| Effect of neuroleptic haloperidol, L-DOPA precursor dopamine, and neurotoxic dopamine analog 6-OHDA on acquisition of conditioned defensive reflex in edible snail. | Bulletin of experimental biology and medicine 20091101 |
| Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats. | Neuroscience letters 20091025 |
| Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats. | Chinese medical journal 20091020 |
| In vivo multimodal imaging of stem cell transplantation in a rodent model of Parkinson's disease. | Journal of neuroscience methods 20091015 |
| TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease. | European journal of pharmacology 20091012 |
| Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. | Stem cells and development 20091001 |
| Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness. | The international journal of neuropsychopharmacology 20091001 |
| Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons. | Experimental neurology 20091001 |
| Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies. | Neurobiology of disease 20091001 |
| Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model. | Experimental neurology 20091001 |
| Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats. | Psychopharmacology 20091001 |
| Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model. | The journal of gene medicine 20091001 |
| The role of the neural sympathetic and parasympathetic systems in diurnal and sleep state-related cardiovascular rhythms in the late-gestation ovine fetus. | American journal of physiology. Regulatory, integrative and comparative physiology 20091001 |
| Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats. | Journal of neurochemistry 20091001 |
| Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway. | British journal of pharmacology 20091001 |
| Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances. | Journal of neural transmission (Vienna, Austria : 1996) 20091001 |
| Effects of chemical sympathectomy on contralateral testicular histology and fertility in unilateral vasectomy. | Journal of Korean medical science 20091001 |
| Kinetics of microglial activation and degeneration of dopamine-containing neurons in a rat model of Parkinson disease induced by 6-hydroxydopamine. | Journal of neuropathology and experimental neurology 20091001 |
| Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist. | Brain research 20090929 |
| Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia. | Neuroreport 20090923 |
| The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease. | Neuroscience 20090915 |
| Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. | Biological psychiatry 20090915 |
| Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice. | Behavioural brain research 20090914 |
| Bilateral high frequency stimulation of the subthalamic nucleus normalizes COX activity in the substantia nigra of Parkinsonian rats. | Brain research 20090908 |
| Response of neural precursor cells in the brain of Parkinson's disease mouse model after LIF administration. | Neurological research 20090901 |
| Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells. | Journal of molecular neuroscience : MN 20090901 |
| Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats. | Experimental neurology 20090901 |
| In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease. | Experimental neurology 20090901 |
| D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. | Neurobiology of disease 20090901 |
| Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles. | The journal of gene medicine 20090901 |
| The electrocorticogram signal can be modulated with deep brain stimulation of the subthalamic nucleus in the hemiparkinsonian rat. | Journal of neurophysiology 20090901 |
| Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling. | The FEBS journal 20090901 |
| Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats. | The European journal of neuroscience 20090901 |
| Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons. | Brain research 20090825 |
| Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease. | Brain research 20090825 |
| [Dual effects of different concentrations of alpha-synuclein on the neurotoxicity of 6-hydroxydopamine in SH-SY5Y cells]. | Sheng li xue bao : [Acta physiologica Sinica] 20090825 |
| Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line-derived neurotrophic factor in the striatum of the rat. | Neuroscience 20090804 |
| Deep brain stimulation of the posterior hypothalamic nucleus reverses akinesia in bilaterally 6-hydroxydopamine-lesioned rats. | Neuroscience 20090804 |
| Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract. | Neuroscience 20090804 |
| Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease. | Neurobiology of disease 20090801 |
| Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatum. | Neurochemical research 20090801 |
| NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease. | Journal of neuroscience research 20090801 |
| Not lost in translation Sensing the loss and filling the gap during regeneration. | Seminars in cell & developmental biology 20090801 |
| Effects of dopamine depletion on network entropy in the external globus pallidus. | Journal of neurophysiology 20090801 |
| Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. | Journal of neurochemistry 20090801 |
| Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCdelta phosphorylation. | Neuroscience bulletin 20090801 |
| Dual-isotope single-photon emission computed tomography for dopamine and serotonin transporters in normal and Parkinsonian monkey brains. | Nuclear medicine and biology 20090801 |
| Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. | The European journal of neuroscience 20090801 |
| Persistent short-term memory defects following sleep deprivation in a drosophila model of Parkinson disease. | Sleep 20090801 |
| [The neuroprotective effects of lesion and high frequency stimulation of the subthalamic nucleus on the substantia nigra neurons]. | Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20090801 |
| Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by l-carnosine in SH-SY5Y cells. | Neuroscience letters 20090731 |
| Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090729 |
| Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease. | Neuroscience letters 20090717 |
| Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. | Biochemical pharmacology 20090715 |
| Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum. | Neurochemical research 20090701 |
| Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease. | Journal of neuroscience research 20090701 |
| Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model. | Journal of neuroscience research 20090701 |
| Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. | Neurobiology of disease 20090701 |
| Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease. | The Journal of comparative neurology 20090701 |
| Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. | Journal of neurochemistry 20090701 |
| Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats. | Journal of neural transmission (Vienna, Austria : 1996) 20090701 |
| Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model. | Turkish neurosurgery 20090701 |
| Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins. | Brain research bulletin 20090630 |
| Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease. | Brain research 20090618 |
| Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats. | Brain research 20090618 |
| Optical imaging of rat prefrontal neuronal activity evoked by stimulation of the ventral tegmental area. | Neuroreport 20090617 |
| Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090617 |
| Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior. | Behavioural brain research 20090608 |
| Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum. | Neuroscience 20090602 |
| Neuroprotective effects of chalcones from Myracrodruon urundeuva on 6-hydroxydopamine-induced cytotoxicity in rat mesencephalic cells. | Neurochemical research 20090601 |
| Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats. | Psychopharmacology 20090601 |
| The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats. | Psychopharmacology 20090601 |
| Parafascicular thalamic nucleus activity in a rat model of Parkinson's disease. | Experimental neurology 20090601 |
| Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. | Pharmacology, biochemistry, and behavior 20090601 |
| Changes to interneuron-driven striatal microcircuits in a rat model of Parkinson's disease. | Neurobiology of disease 20090601 |
| Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP. | Journal of neurochemistry 20090601 |
| Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. | Journal of neurochemistry 20090601 |
| Neural cell protective compounds isolated from Phoenix hanceana var. formosana. | Phytochemistry 20090601 |
| Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum. | Neuroreport 20090527 |
| Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090527 |
| A role for medial prefrontal dopaminergic innervation in instrumental conditioning. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090520 |
| Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression. | Brain research 20090519 |
| Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats. | Behavioural brain research 20090516 |
| Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats. | Journal of neuroscience research 20090515 |
| Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. | Journal of neuroscience research 20090515 |
| Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. | Molecular & cellular proteomics : MCP 20090501 |
| Mobilization of neural stem cells and generation of new neurons in 6-OHDA-lesioned rats by intracerebroventricular infusion of liver growth factor. | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20090501 |
| De novo and long-term l-Dopa induce both common and distinct striatal gene profiles in the hemiparkinsonian rat. | Neurobiology of disease 20090501 |
| Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease. | Journal of neurochemistry 20090501 |
| Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys. | Journal of neurochemistry 20090501 |
| Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats. | Neurotoxicity research 20090501 |
| Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease. | Journal of neurochemistry 20090501 |
| Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease. | Brain, behavior, and immunity 20090501 |
| Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment. | Journal of neurochemistry 20090501 |
| Basolateral amygdala D1- and D2-dopaminergic system promotes the formation of long-term potentiation in the dentate gyrus of anesthetized rats. | Progress in neuro-psychopharmacology & biological psychiatry 20090430 |
| Extracellular dopamine and norepinephrine in the developing rat prefrontal cortex: transient effects of early partial loss of dopamine. | Brain research bulletin 20090429 |
| Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. | Brain research 20090406 |
| Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. | Neuroscience letters 20090403 |
| Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. | The Journal of pharmacology and experimental therapeutics 20090401 |
| Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons. | Neurobiology of disease 20090401 |
| Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats. | Behavioral neuroscience 20090401 |
| Histaminergic activity in a rodent model of Parkinson's disease. | Neurotoxicity research 20090401 |
| Comparing the role of the anterior cingulate cortex and 6-hydroxydopamine nucleus accumbens lesions on operant effort-based decision making. | The European journal of neuroscience 20090401 |
| Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement. | Neurological research 20090401 |
| [Study on the mechanism of electroacupuncture scalp point penetration therapy in action on apoptosis in the Parkinson's disease rat model]. | Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20090401 |
| Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. | Neuroscience 20090331 |
| Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. | Science (New York, N.Y.) 20090320 |
| Modeling operant behavior in the Parkinsonian rat. | Behavioural brain research 20090317 |
| Descending pathways from activated locus coeruleus/subcoeruleus following unilateral hindpaw inflammation in the rat. | Brain research bulletin 20090316 |
| Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model. | Brain research bulletin 20090316 |
| Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. | Biological psychiatry 20090315 |
| The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease. | Journal of neuroscience methods 20090315 |
| PET imaging in rats to discern temporal onset differences between 6-hydroxydopamine and tau gene vector neurodegeneration models. | Brain research 20090309 |
| Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats. | Neuroscience 20090303 |
| Asymmetrical response of aminopeptidase A and nitric oxide in plasma of normotensive and hypertensive rats with experimental hemiparkinsonism. | Neuropharmacology 20090301 |
| Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons. | Neuropharmacology 20090301 |
| Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. | Neurobiology of disease 20090301 |
| Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats. | Neuropharmacology 20090301 |
| Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. | Biological & pharmaceutical bulletin 20090301 |
| Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model. | Brain research 20090227 |
| Dopamine-dependent periadolescent maturation of corticostriatal functional connectivity in mouse. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090225 |
| Subthalamic neurons show increased firing to 5-HT2C receptor activation in 6-hydroxydopamine-lesioned rats. | Brain research 20090223 |
| Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction. | Neuroscience 20090218 |
| L-dopa-induced desensitization depends on 5-hydroxytryptamine imbalance in hemiparkinsonian rats. | Neuroreport 20090218 |
| Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease. | Brain research bulletin 20090216 |
| Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model. | Brain research bulletin 20090216 |
| Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions. | Brain research bulletin 20090216 |
| 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. | Journal of neuroscience research 20090215 |
| Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism. | Brain research 20090213 |
| Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis. | Brain research 20090213 |
| 6-Hydroxydopamine lesion in thalamic reticular nucleus reduces anxiety behaviour in the rat. | Behavioural brain research 20090211 |
| Natural and lesion-induced apoptosis in the rat striatum during development. | Brain research 20090203 |
| Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090201 |
| Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine. | Brain, behavior, and immunity 20090201 |
| Central or peripheral norepinephrine depletion enhances MK-801-induced plasma corticosterone level in mice. | Progress in neuro-psychopharmacology & biological psychiatry 20090201 |
| Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. | Brain : a journal of neurology 20090201 |
| A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats. | British journal of pharmacology 20090201 |
| L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. | Journal of neurochemistry 20090201 |
| Firing activity of locus coeruleus noradrenergic neurons increases in a rodent model of Parkinsonism. | Neuroscience bulletin 20090201 |
| 6-OHDA induces cycle reentry and apoptosis of PC12 cells through activation of ERK1/2 signaling pathway. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20090201 |
| Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study . | Annals of the New York Academy of Sciences 20090201 |
| Modulation of behavior by expected reward magnitude depends on dopamine in the dorsomedial striatum. | Neurotoxicity research 20090201 |
| Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease. | Neurotoxicity research 20090201 |
| [Research progress on pharmacological activities of echinacoside]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20090201 |
| Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats. | Behavioural brain research 20090130 |
| Inhibitory effect of dimethylthiourea on rat urinary bladder inflammation produced by 6-hydroxydopamine application. | Autonomic neuroscience : basic & clinical 20090128 |
| Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats. | Neuroscience 20090123 |
| Both pre- and post-lesion experiential therapy is beneficial in 6-hydroxydopamine dopamine-depleted female rats. | Neuroscience 20090123 |
| Oxidative and inflammatory pathways in Parkinson's disease. | Neurochemical research 20090101 |
| Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model. | Phytotherapy research : PTR 20090101 |
| The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat. | Psychopharmacology 20090101 |
| The neuroprotective effect of dental pulp cells in models of Alzheimer's and Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20090101 |
| Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2. | Neurochemistry international 20090101 |
| Low frequency stimulation of the pedunculopontine nucleus modulates electrical activity of subthalamic neurons in the rat. | Journal of neural transmission (Vienna, Austria : 1996) 20090101 |
| Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. | Neurotoxicology 20090101 |
| Evolution of neurotoxins: from research modalities to clinical realities. | Current protocols in neuroscience 20090101 |
| Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats. | Neuro-Signals 20090101 |
| (-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation. | Journal of Alzheimer's disease : JAD 20090101 |
| [Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?]. | Journal de la Societe de biologie 20090101 |
| Astaxanthin protects neuronal cells against oxidative damage and is a potent candidate for brain food. | Forum of nutrition 20090101 |
| Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats. | Neuropharmacology 20090101 |
| The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons. | Neurotoxicity research 20090101 |
| Nonenzymatic role of acetylcholinesterase in neuritic sprouting: regional changes in acetylcholinesterase and choline acetyltransferase after neonatal 6-hydroxydopamine lesions. | Neurotoxicology and teratology 20090101 |
| Microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters. | Cell transplantation 20090101 |
| Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease. | Journal of neuroinflammation 20090101 |
| Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease. | Journal of translational medicine 20090101 |
| Effect of prenatal manganese intoxication on [(3)H]glucose uptake in the brain of rats lesioned as neonates with 6-hydroxydopamine. | Pharmacological reports : PR 20090101 |
| Organotypic cultures as a model of Parkinson s disease. A twist to an old model. | TheScientificWorldJournal 20090101 |
| [Oxidative stress in the cardiovascular system of rats with chronic deficiency of cerebral dopamine]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20090101 |
| Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair. | Journal of neural transmission. Supplementum 20090101 |
| Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons. | Journal of neural transmission. Supplementum 20090101 |
| RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20081231 |
| Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20081224 |
| Preventive effects of genistein on motor dysfunction following 6-hydroxydopamine injection in ovariectomized rats. | Neuroscience letters 20081219 |
| Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes). | Brain research 20081215 |
| Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. | European journal of pharmacology 20081214 |
| The firing activity of presumed cholinergic and non-cholinergic neurons of the pedunculopontine nucleus in 6-hydroxydopamine-lesioned rats: an in vivo electrophysiological study. | Brain research 20081203 |
| Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism. | Behavioural brain research 20081201 |
| Lrrk2 and alpha-synuclein are co-regulated in rodent striatum. | Molecular and cellular neurosciences 20081201 |
| Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. | Neuropharmacology 20081201 |
| Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease. | Neuroscience research 20081201 |
| Time course changes of the striatum neuropil after unilateral dopamine depletion and the usefulness of the contralateral striatum as a control structure. | Neurological research 20081201 |
| Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. | The Journal of comparative neurology 20081201 |
| Involvement of dopamine D2 receptors in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats. | Neuropharmacology 20081201 |
| Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. | Journal of neurochemistry 20081201 |
| The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA. | Journal of neurochemistry 20081201 |
| JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration. | Journal of neurochemistry 20081201 |
| Covalent arylation of metallothionein by oxidized dopamine products: a possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival. | Neurotoxicity research 20081201 |
| Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonism. | Journal of neurochemistry 20081201 |
| Future of cell and gene therapies for Parkinson's disease. | Annals of neurology 20081201 |
| Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat. | Brain research bulletin 20081125 |
| Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20081119 |
| Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease. | Brain research 20081113 |
| The neuronal activity of thalamic parafascicular nucleus is conversely regulated by nigrostriatal pathway and pedunculopontine nucleus in the rat. | Brain research 20081113 |
| Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization. | The Journal of comparative neurology 20081110 |
| Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model. | Behavioural brain research 20081103 |
| Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: implications for neurodegenerative disorders. | Stress (Amsterdam, Netherlands) 20081101 |
| The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors. | Neurobiology of disease 20081101 |
| Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease. | Neurobiology of disease 20081101 |
| Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats. | Experimental brain research 20081101 |
| The rat heart contains a neural stem cell population; role in sympathetic sprouting and angiogenesis. | Journal of molecular and cellular cardiology 20081101 |
| Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. | Neuroscience research 20081101 |
| Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease. | Clinical and experimental pharmacology & physiology 20081101 |
| Effects of neostriatal 6-OHDA lesion on performance in a rat sequential reaction time task. | Neuroscience letters 20081031 |
| Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia. | Brain research 20081031 |
| Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. | Neuroreport 20081029 |
| Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. | Neuroscience 20081028 |
| Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats. | Brain research 20081021 |
| Neurotrophin-3 reduces apoptosis induced by 6-OHDA in PC12 cells through Akt signaling pathway. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20081001 |
| 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat. | Neuropharmacology 20081001 |
| Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine. | Journal of neurochemistry 20081001 |
| Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. | Free radical biology & medicine 20081001 |
| Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements. | Journal of neural transmission (Vienna, Austria : 1996) 20081001 |
| Pleiotrophin receptor RPTP-zeta/beta expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats. | Journal of neurochemistry 20081001 |
| Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats. | Basic & clinical pharmacology & toxicology 20081001 |
| [Effects of traditional Chinese herbal medicine on the neurobehavioral manifestations and the activity of dopamine D2 receptor in corpora striatum of rats with levodopa-induced dyskinesias]. | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20081001 |
| Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine. | Free radical research 20081001 |
| Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability. | Neurotoxicity research 20081001 |
| Ependymal stem cells divide asymmetrically and transfer progeny into the subventricular zone when activated by injury. | Neuroscience 20080922 |
| Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta. | Neuroscience 20080922 |
| Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. | Neuroscience 20080922 |
| Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. | Toxicology and applied pharmacology 20080915 |
| Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist. | Pharmacology, biochemistry, and behavior 20080901 |
| Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content. | American journal of physiology. Regulatory, integrative and comparative physiology 20080901 |
| Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain. | Experimental neurology 20080901 |
| Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats. | Neuropharmacology 20080901 |
| Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. | Molecular therapy : the journal of the American Society of Gene Therapy 20080901 |
| Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions. | Brain structure & function 20080901 |
| Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: characterization and implantation study. | Biomacromolecules 20080901 |
| Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. | The European journal of neuroscience 20080901 |
| Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats. | Journal of pharmacological sciences 20080901 |
| Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. | Toxicology 20080819 |
| Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress. | Neuroscience letters 20080815 |
| Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic? | Psychopharmacology 20080801 |
| Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease. | Experimental neurology 20080801 |
| Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter. | Synapse (New York, N.Y.) 20080801 |
| Involvement of NCAM in the effects of GDNF on the neurite outgrowth in the dopamine neurons. | Neuroscience research 20080801 |
| Sympathetic histamine exerts different pre- and post-synaptic functions according to the frequencies of nerve stimulation in guinea pig vas deferens. | Journal of neurochemistry 20080801 |
| Patterns of FOS expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats. | The International journal of neuroscience 20080801 |
| Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. | Brain : a journal of neurology 20080801 |
| The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats. | Brain research bulletin 20080730 |
| In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease. | European journal of pharmacology 20080728 |
| Increased electrical and metabolic activity in the dorsal raphe nucleus of Parkinsonian rats. | Brain research 20080724 |
| The coffee diterpene kahweol induces heme oxygenase-1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6-hydroxydopamine-derived oxidative stress. | FEBS letters 20080723 |
| Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease. | Neuroscience letters 20080711 |
| Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease. | Brain research 20080707 |
| Solid lipid nanoparticles as delivery systems for bromocriptine. | Pharmaceutical research 20080701 |
| Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle. | Neurochemical research 20080701 |
| Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model. | Journal of neuroscience research 20080701 |
| Impaired activation of celiac ganglion neurons in vivo after damage to their sympathetic nerve terminals. | Journal of neuroscience research 20080701 |
| Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat. | Synapse (New York, N.Y.) 20080701 |
| Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism. | Journal of neurochemistry 20080701 |
| Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease. | Journal of neuroscience research 20080701 |
| Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism. | Journal of neurochemistry 20080701 |
| Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection. | Journal of neuroimmunology 20080701 |
| Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat. | Journal of neurophysiology 20080701 |
| Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. | Neurobiology of disease 20080701 |
| Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. | Brain : a journal of neurology 20080701 |
| Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins. | Neurotoxicology 20080701 |
| Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. | Biological & pharmaceutical bulletin 20080701 |
| Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells. | Free radical research 20080701 |
| Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens. | The European journal of neuroscience 20080701 |
| Quantitative evaluation of chaperone activity and neuroprotection by different preparations of a cell-penetrating Hsp70. | Journal of neuroscience methods 20080630 |
| Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesions. | Behavioural brain research 20080626 |
| Postmenopausal effects of intrastriatal estrogen on catalepsy and pallidal electroencephalogram in an animal model of Parkinson's disease. | Neuroscience 20080626 |
| Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion. | Neuroscience 20080626 |
| Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration. | Neuroscience 20080626 |
| Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats. | Neuroscience letters 20080613 |
| Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease. | Brain research 20080612 |
| Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine. | Brain research 20080605 |
| Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission. | Behavioural brain research 20080603 |
| Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats. | Neuroscience 20080602 |
| In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. | Synapse (New York, N.Y.) 20080601 |
| Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. | Neurochemistry international 20080601 |
| Increasing extracellular potassium results in subthalamic neuron activity resembling that seen in a 6-hydroxydopamine lesion. | Journal of neurophysiology 20080601 |
| In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway. | Neurobiology of disease 20080601 |
| Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease. | Neuropharmacology 20080601 |
| Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. | Brain : a journal of neurology 20080601 |
| GABAergic mechanism mediated via D receptors in the rat periaqueductal gray participates in the micturition reflex: an in vivo microdialysis study. | The European journal of neuroscience 20080601 |
| The vermicelli handling test: a simple quantitative measure of dexterous forepaw function in rats. | Journal of neuroscience methods 20080530 |
| Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity. | Journal of medicinal chemistry 20080522 |
| Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20080521 |
| 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex. | Journal of neuroscience research 20080515 |
| Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. | Neuroscience 20080515 |
| Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080501 |
| Bilateral changes in neuronal activity of the basal ganglia in the unilateral 6-hydroxydopamine rat model. | Journal of neuroscience research 20080501 |
| Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells. | Neurotoxicology 20080501 |
| Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. | Neurotoxicology 20080501 |
| Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra. | Acta pharmacologica Sinica 20080501 |
| Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20080430 |
| In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats. | European journal of pharmacology 20080428 |
| Alpha-lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1. | Brain research 20080424 |
| Neuronal effects of 4-t-Butylcatechol: a model for catechol-containing antioxidants. | Toxicology and applied pharmacology 20080415 |
| Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. | The Journal of biological chemistry 20080411 |
| A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway. | Brain research 20080408 |
| Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses. | Brain research 20080408 |
| Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. | Brain research 20080408 |
| Sensory (nociceptive) stimulation evokes Fos expression in the subthalamus of hemiparkinsonian rats. | Neurological research 20080401 |
| The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. | Psychopharmacology 20080401 |
| Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease. | Synapse (New York, N.Y.) 20080401 |
| Specific induction of PAG608 in cranial and spinal motor neurons of L-DOPA-treated parkinsonian rats. | Neuroscience research 20080401 |
| Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats. | Experimental neurology 20080401 |
| Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides. | Biochemical pharmacology 20080401 |
| Generation of a alpha-synuclein-based rat model of Parkinson's disease. | Neurobiology of disease 20080401 |
| 7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease. | Experimental and clinical psychopharmacology 20080401 |
| Survival and functional recovery of transplanted human dopaminergic neurons into hemiparkinsonian rats depend on the cannula size of the implantation instrument. | Journal of neuroscience methods 20080330 |
| Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation. | Neuroscience letters 20080315 |
| Additive neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson's model. | Neuroreport 20080305 |
| Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide. | Brain research 20080304 |
| Locus coeruleus noradrenergic neurons and CO2 drive to breathing. | Pflugers Archiv : European journal of physiology 20080301 |
| Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions. | Basic & clinical pharmacology & toxicology 20080301 |
| 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. | Journal of neurochemistry 20080301 |
| Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. | Experimental neurology 20080301 |
| Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease. | Experimental neurology 20080301 |
| Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease. | Biochimica et biophysica acta 20080301 |
| Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions. | The European journal of neuroscience 20080301 |
| Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20080227 |
| Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. | Neuroscience 20080219 |
| Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines. | Toxicology in vitro : an international journal published in association with BIBRA 20080201 |
| Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3. | Journal of neuroscience research 20080201 |
| Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats. | Neurobiology of disease 20080201 |
| l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. | Neurobiology of disease 20080201 |
| Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats. | Neuroscience research 20080201 |
| Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration. | Journal of neuropathology and experimental neurology 20080201 |
| Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA. | The European journal of neuroscience 20080201 |
| [Evaluation of motor disorders in animal models of Parkinson's disease]. | Revista de neurologia 20080201 |
| [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease]. | Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20080201 |
| CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats. | Brain research 20080129 |
| Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain. | Brain research 20080123 |
| Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20080116 |
| Moderate degeneration of nigral neurons after repeated but not after single intrastriatal injections of low doses of 6-hydroxydopamine in mice. | Brain research 20080110 |
| Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action. | Journal of medicinal chemistry 20080110 |
| Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias. | Neuroreport 20080108 |
| Depressed cardiac contractility and its postnatal development in rats after chemical sympathectomy. | Physiological research 20080101 |
| Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. | Journal of neuroscience research 20080101 |
| Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. | The international journal of biochemistry & cell biology 20080101 |
| Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. | European journal of nuclear medicine and molecular imaging 20080101 |
| Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. | Neurobiology of disease 20080101 |
| Interaction of dopamine and adenosine receptor function in behavior: studies with dopamine-deficient mice. | Frontiers in bioscience : a journal and virtual library 20080101 |
| Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats? | Parkinsonism & related disorders 20080101 |
| Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. | Experimental neurology 20080101 |
| Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease. | The European journal of neuroscience 20080101 |
| Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease. | The European journal of neuroscience 20080101 |
| Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398. | Journal of neural transmission (Vienna, Austria : 1996) 20080101 |
| Olfactory ensheathing cells conditioned medium prevented apoptosis induced by 6-OHDA in PC12 cells through modulation of intrinsic apoptotic pathways. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20080101 |
| Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. | Journal of neuroinflammation 20080101 |
| Similar pathological effects of sympathectomy and hypercholesterolemia on arterial smooth muscle cells and fibroblasts. | Acta histochemica 20080101 |
| [Compensatory reaction during degeneration of arcuate nucleus dopaminergic neurons in rats]. | Zhurnal evoliutsionnoi biokhimii i fiziologii 20080101 |
| [Compensatory effect of selank on the mnestic functions disturbed by neurotoxic damage of the noradrenergic system of the rat brain]. | Eksperimental'naia i klinicheskaia farmakologiia 20080101 |
| Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease. | Journal of neuroinflammation 20080101 |
| Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum. | Neurotoxicity research 20080101 |
| Mesencephalic human neural progenitor cells transplanted into the adult hemiparkinsonian rat striatum lack dopaminergic differentiation but improve motor behavior. | Cells, tissues, organs 20080101 |
| Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence. | Parkinsonism & related disorders 20080101 |
| Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. | Autophagy 20080101 |
| The 6-hydroxydopamine model: news from the past. | Parkinsonism & related disorders 20080101 |
| Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. | Parkinsonism & related disorders 20080101 |
| Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. | BMC neuroscience 20080101 |
| [Antioxidants prevent experimental hemiparkinsonism in rats]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20080101 |
| Signaling pathways controlling neural stem cells slow progressive brain disease. | Cold Spring Harbor symposia on quantitative biology 20080101 |
| Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain. | Cell transplantation 20080101 |
| Use of rotorod as a method for the qualitative analysis of walking in rat. | Journal of visualized experiments : JoVE 20080101 |
| Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. | Autonomic neuroscience : basic & clinical 20071230 |
| RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20071226 |
| Activating transcription factor 3 induction in sympathetic neurons after axotomy: response to decreased neurotrophin availability. | Neuroscience 20071219 |
| Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. | Biological psychiatry 20071215 |
| Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration. | European journal of pharmacology 20071208 |
| Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats. | Behavioural brain research 20071203 |
| Echinacoside prevents the striatal extracellular levels of monoamine neurotransmitters from diminution in 6-hydroxydopamine lesion rats. | Journal of ethnopharmacology 20071203 |
| Cell stress induced by the parkinsonian mimetic, 6-hydroxydopamine, is concurrent with oxidation of the chaperone, ERp57, and aggresome formation. | Antioxidants & redox signaling 20071201 |
| Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells. | The Journal of pharmacology and experimental therapeutics 20071201 |
| K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways. | Molecular pharmacology 20071201 |
| Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene. | Synapse (New York, N.Y.) 20071201 |
| Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model. | Neuropharmacology 20071201 |
| Pael receptor is involved in dopamine metabolism in the nigrostriatal system. | Neuroscience research 20071201 |
| Hydroxylated serotonin and dopamine as substrates and inhibitors for human cytosolic SULT1A3. | Journal of neurochemistry 20071201 |
| A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress. | American journal of physiology. Cell physiology 20071201 |
| Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats. | Neuropharmacology 20071201 |
| Resonant antidromic cortical circuit activation as a consequence of high-frequency subthalamic deep-brain stimulation. | Journal of neurophysiology 20071201 |
| Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling. | Journal of neurochemistry 20071201 |
| Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in vivo voltammetry study. | Neuropharmacology 20071201 |
| Effects of Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in cultured PC12. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20071201 |
| Interactions between dopamine and melatonin organize circadian rhythmicity in the retina of the green iguana. | Journal of biological rhythms 20071201 |
| Expression of FasL and its interaction with Fas are mediated by c-Jun N-terminal kinase (JNK) pathway in 6-OHDA-induced rat model of Parkinson disease. | Neuroscience letters 20071127 |
| Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. | The Journal of biological chemistry 20071123 |
| Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism. | Behavioural brain research 20071122 |
| The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing. | Behavioural brain research 20071102 |
| Spatial deficits in a mouse model of Parkinson disease. | Psychopharmacology 20071101 |
| Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. | Journal of neuroscience research 20071101 |
| The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases. | Journal of neurochemistry 20071101 |
| Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. | Journal of neurochemistry 20071101 |
| NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats. | Journal of neurochemistry 20071101 |
| Distribution and immunohistochemical localization of GDNF protein in selected neural and non-neural tissues of rats during development and changes in unilateral 6-hydroxydopamine lesions. | Neuroscience research 20071101 |
| Neuroprotection and free radical scavenging effects of Osmanthus fragrans. | Journal of biomedical science 20071101 |
| PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. | Journal of neuroscience research 20071101 |
| Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. | Experimental neurology 20071101 |
| Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. | Nature neuroscience 20071101 |
| Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells. | Neuroreport 20071029 |
| Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease. | Brain research 20071024 |
| Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. | FEBS letters 20071016 |
| Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons. | Journal of neuroscience methods 20071015 |
| Transforming growth factor-beta in the brain enhances fat oxidation via noradrenergic neurons in the ventromedial and paraventricular hypothalamic nucleus. | Brain research 20071010 |
| Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa. | Neuroscience letters 20071009 |
| Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. | Journal of neurochemistry 20071001 |
| ANG II-induced attenuation of salt gland function in Pekin ducks is not catecholamine-dependent. | Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20071001 |
| Effect of ventrolateral thalamic nucleus lesions in the unilateral 6-hydroxydopamine rat model. | Behavioural brain research 20071001 |
| Experimental change on dopaminergic neurons in striatum of Parkinson disease rats. | Histology and histopathology 20071001 |
| Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. | Journal of neurochemistry 20071001 |
| Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro. | Journal of neurochemistry 20071001 |
| rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease. | Experimental neurology 20071001 |
| MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats. | Peptides 20071001 |
| Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease. | Journal of pineal research 20071001 |
| Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins. | Journal of proteome research 20071001 |
| Manganese-enhanced MRI in a rat model of Parkinson's disease. | Journal of magnetic resonance imaging : JMRI 20071001 |
| Dopamine lesion-induced changes in subthalamic nucleus activity are not associated with alterations in firing rate or pattern in layer V neurons of the anterior cingulate cortex in anesthetized rats. | The European journal of neuroscience 20071001 |
| Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. | Current protocols in neuroscience 20071001 |
| Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. | Physiology & behavior 20070910 |
| High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats. | Neuroscience 20070907 |
| Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20070905 |
| Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. | Behavioural brain research 20070904 |
| Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070901 |
| Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070901 |
| A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. | Journal of neurochemistry 20070901 |
| Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats. | Neuroscience research 20070901 |
| Peripheral bee venom's anti-inflammatory effect involves activation of the coeruleospinal pathway and sympathetic preganglionic neurons. | Neuroscience research 20070901 |
| Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss. | Experimental neurology 20070901 |
| NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells. | Chemical research in toxicology 20070901 |
| Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson's disease experimental models. | The European journal of neuroscience 20070901 |
| High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats. | The European journal of neuroscience 20070901 |
| Evaluation of neuroprotective and anti-fatigue effects of sildenafil. | Life sciences 20070901 |
| Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801. | Neurotoxicity research 20070901 |
| Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons. | Neurotoxicity research 20070901 |
| Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. | Neuroscience letters 20070809 |
| G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway. | Neurobiology of aging 20070801 |
| Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum. | Journal of neurochemistry 20070801 |
| 6-Hydroxydopamine induces mitochondrial ERK activation. | Free radical biology & medicine 20070801 |
| Midbrain dopaminergic neurogenesis and behavioural recovery in a salamander lesion-induced regeneration model. | Development (Cambridge, England) 20070801 |
| Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum. | Journal of neurochemistry 20070801 |
| An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20070801 |
| The regulation of liver cytochrome p450 by the brain dopaminergic system. | Current drug metabolism 20070801 |
| D-beta-hydroxybutyrate inhibits the apoptosis of PC12 cells induced by 6-OHDA in relation to up-regulating the ratio of Bcl-2/Bax mRNA. | Autonomic neuroscience : basic & clinical 20070731 |
| Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats. | Brain research 20070730 |
| Nicotine's attenuation of body weight involves the perifornical hypothalamus. | Life sciences 20070719 |
| A comparison of dopaminergic cells from the human NTera2/D1 cell line transplanted into the hemiparkinsonian rat. | Life sciences 20070719 |
| The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. | Brain research 20070716 |
| Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. | Neuroreport 20070716 |
| Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. | Nature 20070705 |
| Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. | European journal of pharmacology 20070702 |
| In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070701 |
| Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. | Brain : a journal of neurology 20070701 |
| Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats. | NeuroImage 20070701 |
| Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats. | Neurobiology of disease 20070701 |
| AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease. | Neurobiology of disease 20070701 |
| Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. | Neuropharmacology 20070701 |
| Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20070701 |
| The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease. | The European journal of neuroscience 20070701 |
| [Effects of tetramethylpyrazine on brain oxidative damage induced by intracerebral perfusion of L-DOPA in rats with Parkinson's disease]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070701 |
| Protective effects of fustin, a flavonoid from Rhus verniciflua Stokes, on 6-hydroxydopamine-induced neuronal cell death. | Experimental & molecular medicine 20070630 |
| Neural plasticity maintained high by activation of cyclic AMP-dependent protein kinase: an age-independent, general mechanism in cat striate cortex. | Neuroscience 20070629 |
| Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors. | Neuroscience letters 20070629 |
| Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20070627 |
| Determination of endogenous norepinephrine levels in different chambers of the rat heart by capillary electrophoresis coupled with amperometric detection. | Journal of neuroscience methods 20070615 |
| Changes in the content of estrogen alpha and progesterone receptors during differentiation of mouse embryonic stem cells to dopamine neurons. | Brain research bulletin 20070615 |
| Dopaminergic differentiation of grafted GFP transgenic neuroepithelial stem cells in the brain of a rat model of Parkinson's disease. | Neuroscience letters 20070608 |
| Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons. | Journal of neurochemistry 20070601 |
| Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. | Synapse (New York, N.Y.) 20070601 |
| Inotropic, chronotropic, and arrhythmogenic effects of dopamine on the isolated working heart of rabbit. | The journal of physiological sciences : JPS 20070601 |
| Role of the midbrain dopaminergic system in modulation of vocal brain activation by social context. | The European journal of neuroscience 20070601 |
| Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat. | The European journal of neuroscience 20070601 |
| Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat. | The European journal of neuroscience 20070601 |
| Assessing an eating disorder induced by 6-OHDA and the possibility of nerve regeneration therapy by transplantation of neural progenitor cells in rats. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20070601 |
| 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus alters neuronal activity of the subthalamic nucleus in normal and 6-hydroxydopamine-lesioned rats. | Brain research 20070529 |
| Early inhibition of TNFalpha increases 6-hydroxydopamine-induced striatal degeneration. | Brain research 20070525 |
| Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. | Neuroscience 20070525 |
| Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats. | Neuroscience letters 20070523 |
| Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease. | Behavioural brain research 20070516 |
| NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53. | Brain research 20070511 |
| [Proteolytic stress induced by environmental toxins in dopaminergic neurons: an experimental study]. | Zhonghua yi xue za zhi 20070508 |
| Nrf2-mediated protection against 6-hydroxydopamine. | Brain research 20070504 |
| Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease. | Psychopharmacology 20070501 |
| Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. | Experimental neurology 20070501 |
| Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats. | Journal of psychiatry & neuroscience : JPN 20070501 |
| Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. | Journal of neuropathology and experimental neurology 20070501 |
| Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. | The European journal of neuroscience 20070501 |
| Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats. | The European journal of neuroscience 20070501 |
| Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson's disease. | Neuroscience bulletin 20070501 |
| The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells. | European journal of pharmacology 20070430 |
| Intracerebral co-transplantation of liposomal tacrolimus improves xenograft survival and reduces graft rejection in the hemiparkinsonian rat. | Neuroscience 20070425 |
| Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease. | Sheng li xue bao : [Acta physiologica Sinica] 20070425 |
| Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease. | Brain research 20070420 |
| Alpha-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells. | Neuroscience letters 20070418 |
| [Effect of 6-hydroxydopamine on the levels of phosphorylation of signal transduction and transcription factor 1 and 3: experiment with dopaminergic neurons]. | Zhonghua yi xue za zhi 20070417 |
| Neural-tube-derived neuroepithelial stem cells: a new transplant resource for Parkinson's disease. | Neuroreport 20070416 |
| Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo. | Journal of the neurological sciences 20070415 |
| Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. | Neurobiology of aging 20070401 |
| Protective effect of sulforaphane against dopaminergic cell death. | The Journal of pharmacology and experimental therapeutics 20070401 |
| Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. | Journal of neuroscience research 20070401 |
| Enhancement of dopaminergic properties and protection mediated by neuronal activation of Ras in mouse ventral mesencephalic neurones. | The European journal of neuroscience 20070401 |
| The 6-hydroxydopamine model of Parkinson's disease. | Neurotoxicity research 20070401 |
| The blood-brain barrier for catecholamines - revisited. | Neurotoxicity research 20070401 |
| The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models. | Neurological research 20070401 |
| Effects of desensitized nicotinic receptors on rotational behavior in a 6-hydroxydopamine model of Parkinson's disease. | Neuroscience letters 20070330 |
| Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata. | Neuroscience 20070316 |
| Effects of 2,3-benzodiazepine AMPA receptor antagonists on dopamine turnover in the striatum of rats with experimental parkinsonism. | Brain research bulletin 20070315 |
| Influence of autophagy genes on ion-channel-dependent neuronal degeneration in Caenorhabditis elegans. | Journal of cell science 20070315 |
| Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons. | Brain research 20070302 |
| Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease. | Parkinsonism & related disorders 20070301 |
| Sympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neurons. | Regulatory peptides 20070301 |
| The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias. | Neurobiology of disease 20070301 |
| Transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the neonatal parkinsonian rat caudate putamen. | Journal of neuroscience research 20070301 |
| Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line--studies in vitro and after intracerebral grafting in vivo. | Molecular and cellular neurosciences 20070301 |
| 6-Hydroxydopamine induces cystatin C-mediated cysteine protease suppression and cathepsin D activation. | Neurochemistry international 20070301 |
| Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. | Neurochemical research 20070301 |
| Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. | Free radical biology & medicine 20070301 |
| Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. | Biological & pharmaceutical bulletin 20070301 |
| Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model. | Journal of pharmacological sciences 20070301 |
| Signalling pathways underlying neural cell adhesion molecule-mediated survival of dopaminergic neurons. | The European journal of neuroscience 20070301 |
| Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats. | The European journal of neuroscience 20070301 |
| Impact of 6-hydroxydopamine lesions and cocaine exposure on mu-opioid receptor expression and regulation of cholinergic transmission in the limbic-prefrontal territory of the rat dorsal striatum. | The European journal of neuroscience 20070301 |
| Sequential bilateral striatal lesions have additive effects on single skilled limb use in rats. | Behavioural brain research 20070227 |
| Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. | Brain research 20070223 |
| Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. | The Journal of biological chemistry 20070216 |
| Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats. | Brain research 20070216 |
| The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of l-dopa in unilaterally 6-OHDA-lesioned rats. | Brain research 20070216 |
| Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy. | Movement disorders : official journal of the Movement Disorder Society 20070215 |
| The 'motor complication syndrome' in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration. | Behavioural brain research 20070212 |
| Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease. | Neuroscience 20070209 |
| Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. | Neuroscience 20070209 |
| Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats. | Neuroscience 20070209 |
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. | Nature 20070208 |
| The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20070207 |
| GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease. | Neuroscience letters 20070202 |
| Effect of antidepressant drugs on 6-OHDA-treated mice in the FST. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070201 |
| The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070201 |
| Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. | Journal of neurochemistry 20070201 |
| Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates. | Neuropharmacology 20070201 |
| The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems. | British journal of pharmacology 20070201 |
| Does chemical sympathectomy alter the ontogeny of gubernacular migration in vivo? | Journal of pediatric surgery 20070201 |
| Bilateral high-frequency stimulation of the subthalamic nucleus on attentional performance: transient deleterious effects and enhanced motivation in both intact and parkinsonian rats. | The European journal of neuroscience 20070201 |
| Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex. | Neurotoxicity research 20070201 |
| Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. | Neurotoxicity research 20070201 |
| Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease. | Journal of neuroscience methods 20070130 |
| Role of sympathetic nerves on early embryonic development and immune modulation of uterus in pregnant mice. | Autonomic neuroscience : basic & clinical 20070130 |
| Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine. | Neuroscience 20070119 |
| Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20070117 |
| Proapoptotic Nix activates the JNK pathway by interacting with POSH and mediates death in a Parkinson disease model. | The Journal of biological chemistry 20070112 |
| Expression pattern of JunD after acute or chronic L-DOPA treatment: comparison with deltaFosB. | Neuroscience 20070105 |
| A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo. | Brain research 20070105 |
| Neurotoxicity assessment using zebrafish. | Journal of pharmacological and toxicological methods 20070101 |
| Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity. | Neurotoxicology 20070101 |
| Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. | The Journal of pharmacology and experimental therapeutics 20070101 |
| Nifedipine suppresses self-injurious behaviors in animals. | Developmental neuroscience 20070101 |
| Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. | Brain : a journal of neurology 20070101 |
| Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease. | Neurochemical research 20070101 |
| Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070101 |
| Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression. | The European journal of neuroscience 20070101 |
| Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study. | The European journal of neuroscience 20070101 |
| Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. | The European journal of neuroscience 20070101 |
| Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. | Neuroscience and biobehavioral reviews 20070101 |
| Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism. | Acta neurochirurgica 20070101 |
| Modification of L-DOPA pharmacological activity by MAO inhibitors. | Journal of neural transmission (Vienna, Austria : 1996) 20070101 |
| Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA. | Journal of molecular neuroscience : MN 20070101 |
| The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. | Pharmacology, biochemistry, and behavior 20070101 |
| Nonhuman primate models of Parkinson's disease. | ILAR journal 20070101 |
| A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere. | Restorative neurology and neuroscience 20070101 |
| Reversible unilateral nigrostriatal pathway inhibition induced through expression of adenovirus-mediated clostridial light chain gene in the substantia nigra. | Neuromolecular medicine 20070101 |
| Protective effect of (+/-) isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells. | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20070101 |
| [The experimental models of Parkinson's disease in animals]. | Uspekhi fiziologicheskikh nauk 20070101 |
| Early pubertal female rats are more resistant than males to 6-hydroxydopamine neurotoxicity and behavioural deficits: a possible role for trophic factors. | Restorative neurology and neuroscience 20070101 |
| Assessment of antioxidative activity of extract from fermented grain food mixture using chemical and cellular systems. | BioFactors (Oxford, England) 20070101 |
| Functionality of NGF-protected PC12 cells following exposure to 6-hydroxydopamine. | Biochemical and biophysical research communications 20061229 |
| Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20061227 |
| Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum. | Neuroscience letters 20061220 |
| Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. | Journal of neuroscience methods 20061215 |
| Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. | European journal of pharmacology 20061215 |
| Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist. | European journal of pharmacology 20061215 |
| Subchronic administration of L-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata. | Brain research 20061206 |
| [Phosphorylation of PKCdelta participates in the toxicity of 6-hydroxydopamine on dopaminergic neuroblastoma cell]. | Zhonghua yi xue za zhi 20061205 |
| L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors. | Journal of neural transmission (Vienna, Austria : 1996) 20061201 |
| Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease. | Gene therapy 20061201 |
| Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate. | Stem cells (Dayton, Ohio) 20061201 |
| A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine. | Toxicology in vitro : an international journal published in association with BIBRA 20061201 |
| Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior. | Neuroscience 20061201 |
| Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats. | Molecular therapy : the journal of the American Society of Gene Therapy 20061201 |
| Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease. | Neurobiology of disease 20061201 |
| Modulation by 6-hydroxydopamine of expression of the phenylethanolamine N-methyltransferase (PNMT) gene in the rat heart during immobilization stress. | Stress (Amsterdam, Netherlands) 20061201 |
| Unilateral ibotenic acid lesions of the prefrontal cortex reduce rotational behavior in 6-hydroxydopamine-lesioned rats. | Acta medica Okayama 20061201 |
| Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex. | Neuroreport 20061127 |
| Ondamtanggamibang protects neurons from oxidative stress with induction of heme oxygenase-1. | Journal of ethnopharmacology 20061124 |
| Improvements in motor behavioral tests during deep brain stimulation of the subthalamic nucleus in rats with different degrees of unilateral parkinsonism. | Brain research 20061120 |
| Protection of nigral cell death by bilateral subthalamic nucleus stimulation. | Brain research 20061120 |
| A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity. | Neuroscience 20061117 |
| Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromaffin cell transplant. | Journal of neuroscience research 20061115 |
| A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models. | Free radical biology & medicine 20061115 |
| Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists. | Experimental neurology 20061101 |
| Potentiation of in vivo neuroprotection by BclX(L) and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons. | Gene therapy 20061101 |
| Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats. | Amino acids 20061101 |
| Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease. | Molecular therapy : the journal of the American Society of Gene Therapy 20061101 |
| Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease. | Behavioural brain research 20061101 |
| Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. | Journal of neuroscience research 20061101 |
| Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning. | Journal of neurochemistry 20061101 |
| Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression. | Neurobiology of disease 20061101 |
| Fos immunoreactivity in some locomotor neural centres of 6OHDA-lesioned rats. | Anatomy and embryology 20061101 |
| Catha edulis extract and its active principle cathinone induce ipsilateral rotation in unilaterally lesioned rats. | Behavioural pharmacology 20061101 |
| Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats. | Neurochemical research 20061101 |
| Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. | Nature medicine 20061101 |
| Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias. | Journal of the neurological sciences 20061025 |
| Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease. | Brain research 20061020 |
| A method for a more complete in vitro Parkinson's model: slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuit. | Journal of neuroscience methods 20061015 |
| Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway. | Brain research 20061003 |
| CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway. | Neuroscience letters 20061002 |
| Locus coeruleus is a central chemoreceptive site in toads. | American journal of physiology. Regulatory, integrative and comparative physiology 20061001 |
| Behavioral models of Parkinson's disease in rodents: a new look at an old problem. | Movement disorders : official journal of the Movement Disorder Society 20061001 |
| PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. | Neurobiology of disease 20061001 |
| Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics. | Journal of neurochemistry 20061001 |
| Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain. | Journal of pharmacological sciences 20061001 |
| Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model. | The European journal of neuroscience 20061001 |
| Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. | The European journal of neuroscience 20061001 |
| Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat. | The Indian journal of medical research 20061001 |
| Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. | European journal of pharmacology 20060928 |
| Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions. | Brain research 20060927 |
| RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060927 |
| Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway. | The Journal of comparative neurology 20060920 |
| Neuroanatomical localization of an internal clock: a functional link between mesolimbic, nigrostriatal, and mesocortical dopaminergic systems. | Brain research 20060913 |
| Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060913 |
| Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060913 |
| Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats. | Neuroscience 20060901 |
| Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk. | Neurobiology of disease 20060901 |
| Quebrachitol (2-O-methyl-L-inositol) attenuates 6-hydroxydopamine-induced cytotoxicity in rat fetal mesencephalic cell cultures. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20060901 |
| Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway. | Journal of neuroscience research 20060901 |
| On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease. | Experimental neurology 20060901 |
| Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle. | Neuropharmacology 20060901 |
| Phosphoproteomic profiling of human SH-SY5Y neuroblastoma cells during response to 6-hydroxydopamine-induced oxidative stress. | Biochimica et biophysica acta 20060901 |
| Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease. | Indian journal of experimental biology 20060901 |
| Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission. | The European journal of neuroscience 20060901 |
| Proliferation of neural precursors in the subventricular zone after chemical lesions of the nigrostriatal pathway in rat brain. | Brain research 20060823 |
| Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity. | Life sciences 20060822 |
| KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity. | Journal of neuroscience research 20060815 |
| Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat. | Brain research 20060802 |
| The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats. | Neuroscience research 20060801 |
| Field potential recording in the ventral tegmental area: pharmacological and toxicological evaluations of postsynaptic dopaminergic neuron activity. | Neuroscience research 20060801 |
| Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra. | Acta neuropathologica 20060801 |
| Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats. | Neuropeptides 20060801 |
| Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats. | Neurotoxicity research 20060801 |
| Dopamine stimulation via infusion in the lateral ventricle. | Annals of the New York Academy of Sciences 20060801 |
| Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures. | Annals of the New York Academy of Sciences 20060801 |
| Effect of subthalamic nucleus lesions in a 6-hydroxydopamine-induced rat parkinsonian model: behavioral and biochemical studies. | Journal of neurosurgery 20060801 |
| Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. | Brain research 20060726 |
| A novel therapeutic approach to 6-OHDA-induced Parkinson's disease in rats via supplementation of PTD-conjugated tyrosine hydroxylase. | Biochemical and biophysical research communications 20060721 |
| Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment. | Behavioural brain research 20060715 |
| FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates. | Journal of medicinal chemistry 20060713 |
| Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. | Neuroscience letters 20060710 |
| Role for dopamine neurons of the rostral linear nucleus and periaqueductal gray in the rewarding and sensitizing properties of heroin. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060701 |
| Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats. | American journal of physiology. Regulatory, integrative and comparative physiology 20060701 |
| Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease. | Synapse (New York, N.Y.) 20060701 |
| Evidence for disease-regulated transgene expression in the brain with use of lentiviral vectors. | Journal of neuroscience research 20060701 |
| Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure. | Hypertension (Dallas, Tex. : 1979) 20060701 |
| Differential involvement of intracellular Ca2+ in 1-methyl-4-phenylpyridinium- or 6-hydroxydopamine-induced cell viability loss in PC12 cells. | Neurochemical research 20060701 |
| Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. | Pharmacology, biochemistry, and behavior 20060701 |
| Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease. | Annals of the New York Academy of Sciences 20060701 |
| Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease. | Human & experimental toxicology 20060701 |
| Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. | The European journal of neuroscience 20060701 |
| Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon? | Behavioural brain research 20060630 |
| Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. | The Journal of biological chemistry 20060630 |
| Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease. | Brain research 20060620 |
| Nigral injection of antisense oligonucleotides to synaptotagmin I using HVJ-liposome vectors causes disruption of dopamine release in the striatum and impaired skill learning. | Brain research 20060620 |
| Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions. | Synapse (New York, N.Y.) 20060615 |
| Colour-coded pellets increase the sensitivity of the staircase test to differentiate skilled forelimb performances of control and 6-hydroxydopamine lesioned rats. | Brain research bulletin 20060615 |
| Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease. | Brain research 20060606 |
| Oxidation and cytotoxicity of 6-OHDA are mediated by reactive intermediates of COX-2 overexpressed in PC12 cells. | Brain research 20060606 |
| Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. | Experimental neurology 20060601 |
| Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats. | Synapse (New York, N.Y.) 20060601 |
| L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase. | Neuropharmacology 20060601 |
| Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test. | Synapse (New York, N.Y.) 20060601 |
| Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. | Neurobiology of disease 20060601 |
| Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. | Apoptosis : an international journal on programmed cell death 20060601 |
| Substantial role of locus coeruleus-noradrenergic activation and capsaicin-insensitive primary afferent fibers in bee venom's anti-inflammatory effect. | Neuroscience research 20060601 |
| Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: effect of immunosuppression with cyclosporine A. | Parkinsonism & related disorders 20060601 |
| Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. | Pharmacology, biochemistry, and behavior 20060601 |
| Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20060601 |
| Further validation of the corridor task for assessing deficit and recovery in the hemi-Parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism. | Behavioural brain research 20060515 |
| L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. | Neuroscience letters 20060508 |
| On the retention of neurotensin in the ventral tegmental area (VTA) despite destruction of the main neurotensinergic afferents of the VTA--implications for the organization of forebrain projections to the VTA. | Brain research 20060504 |
| Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats. | Journal of neural transmission (Vienna, Austria : 1996) 20060501 |
| The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. | Neurobiology of disease 20060501 |
| Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. | Neuroscience letters 20060501 |
| Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat. | Neuropharmacology 20060501 |
| Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats. | Movement disorders : official journal of the Movement Disorder Society 20060501 |
| 6-Hydroxydopamine lesions of nucleus accumbens core abolish amphetamine-induced conditioned activity. | Synapse (New York, N.Y.) 20060501 |
| Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Neurobiology of disease 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus. | The European journal of neuroscience 20060501 |
| Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells. | Neurochemical research 20060501 |
| MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation. | The European journal of neuroscience 20060501 |
| Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway. | The Journal of biological chemistry 20060428 |
| Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease. | Behavioural brain research 20060425 |
| Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions. | Behavioural brain research 20060425 |
| Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment. | Brain research 20060421 |
| Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. | Brain research bulletin 20060414 |
| 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. | The Journal of biological chemistry 20060407 |
| Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. | Neurobiology of disease 20060401 |
| Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease. | Neurobiology of disease 20060401 |
| Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats. | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20060401 |
| Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. | Neurochemistry international 20060401 |
| Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. | Journal of neurochemistry 20060401 |
| Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats. | The European journal of neuroscience 20060401 |
| Neuroprotective bibenzyl glycosides of Stemona tuberosa roots. | Journal of natural products 20060401 |
| Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. | Neurochemical research 20060401 |
| Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease. | Endocrine 20060401 |
| Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. | Life sciences 20060320 |
| Modulation of torsinA expression in the globus pallidus internus is associated with levodopa-induced dyskinesia in hemiparkinsonian rats. | Neuroscience letters 20060320 |
| A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060315 |
| 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. | The Journal of biological chemistry 20060303 |
| Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. | Neurochemistry international 20060301 |
| Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat. | Molecular pharmacology 20060301 |
| Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure. | Neurotoxicology 20060301 |
| Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. | Journal of neurochemistry 20060301 |
| [Effect of prepared radix Polygoni multiflori on the elevation of extracellular hydroxyl radical in striatum of rats induced by intracerebral perfusion of 6-hydroxy dopamine]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20060301 |
| Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity. | Phytotherapy research : PTR 20060301 |
| Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. | Brain research 20060216 |
| Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems. | Brain research 20060216 |
| Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease? | Experimental neurology 20060201 |
| The signal transduction pathway for the dopamine D1 receptor in the guinea-pig cochlea. | Neuroscience 20060201 |
| Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time? | Experimental neurology 20060201 |
| Circadian distribution of motor-activity in unilaterally 6-hydroxy-dopamine lesioned rats. | Experimental brain research 20060201 |
| Increased galanin expression in the celiac ganglion of BB diabetic rats. | Neuropeptides 20060201 |
| Functional investigations into the role of dopamine and serotonin in partial bilateral striatal 6-hydroxydopamine lesioned rats. | Pharmacology, biochemistry, and behavior 20060201 |
| Neglect of memory after dopaminergic lesions in monkeys. | Behavioural brain research 20060130 |
| Differing influence of sympathectomy on smooth muscle cells and fibroblasts in cerebral and peripheral muscular arteries. | Autonomic neuroscience : basic & clinical 20060130 |
| Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice. | Neuroscience letters 20060123 |
| Adaptive response induced by lipid peroxidation products in cell cultures. | FEBS letters 20060123 |
| Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein. | Experimental cell research 20060115 |
| Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. | Brain research 20060112 |
| Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease. | Brain research 20060112 |
| Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060111 |
| UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101 |
| Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease. | Neurobiology of disease 20060101 |
| Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease. | Neurobiology of disease 20060101 |
| Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. | Neurobiology of disease 20060101 |
| Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats. | Molecular therapy : the journal of the American Society of Gene Therapy 20060101 |
| ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. | Biological psychiatry 20060101 |
| Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat. | Neuropharmacology 20060101 |
| Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals. | Synapse (New York, N.Y.) 20060101 |
| Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease. | Experimental neurology 20060101 |
| Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. | Experimental neurology 20060101 |
| Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. | Neuroscience 20060101 |
| Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex. | Psychopharmacology 20060101 |
| Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. | Journal of neurochemistry 20060101 |
| Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. | Neuroscience 20060101 |
| Adrenergic modulation of the type 1 IP3 receptors in the rat heart. | Biochimica et biophysica acta 20060101 |
| Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease. | The European journal of neuroscience 20060101 |
| A new neuroprotective compound of Ligustrum japonicum leaves. | Planta medica 20060101 |
| Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. | Pharmacology, biochemistry, and behavior 20060101 |
| Sympathectomy causes aggravated lesions and dedifferentiation in large rabbit atherosclerotic arteries without involving nitric oxide. | Journal of vascular research 20060101 |
| Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. | Cell transplantation 20060101 |
| Neural repair strategies for Parkinson's disease: insights from primate models. | Cell transplantation 20060101 |
| Histochemical study of cardiac mast cells degranulation and collagen deposition: interaction with the cathecolaminergic system in the rat. | European journal of histochemistry : EJH 20060101 |
| Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography. | Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20060101 |
| [Inhibitors of mitochondrial permeability transition pore prevent apoptosis of dopaminergic neurons in the mesencephalon]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20060101 |
| Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD). | Journal of neural transmission. Supplementum 20060101 |
| Proposed animal model of severe Parkinson's disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum. | Journal of neural transmission. Supplementum 20060101 |
| Bridging nigrostriatal pathway with fibroblast growth factor-primed peripheral nerves and fetal ventral mesencephalon transplant recuperates from deficits in parkinsonian rats. | Cell transplantation 20060101 |
| Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease. | Cell transplantation 20060101 |
| Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases. | Journal of neural transmission. Supplementum 20060101 |
| DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. | The Journal of biological chemistry 20051230 |
| Marmoset monkey models of Parkinson's disease: which model, when and why? | Brain research bulletin 20051230 |
| The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats. | European journal of pharmacology 20051228 |
| Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists. | Brain research bulletin 20051215 |
| The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum. | Brain research bulletin 20051215 |
| Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age. | Brain research bulletin 20051215 |
| Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy. | Brain research bulletin 20051215 |
| Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in rats using a lateralised nose-poking task with low stimulus-response compatibility. | Behavioural brain research 20051207 |
| Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease. | Behavioural brain research 20051207 |
| Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats. | Brain research 20051207 |
| Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures. | Neurobiology of disease 20051201 |
| Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system. | Experimental neurology 20051201 |
| Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions. | Brain : a journal of neurology 20051201 |
| Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists. | Behavioural pharmacology 20051201 |
| A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. | Brain research. Brain research protocols 20051201 |
| Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice. | Journal of pharmacological sciences 20051201 |
| Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease. | The European journal of neuroscience 20051201 |
| Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism. | The European journal of neuroscience 20051201 |
| Alterations in the development of rat cerebellum and impaired behavior of juvenile rats after neonatal 6-OHDA treatment. | Neurochemical research 20051201 |
| Involvement of catecholamine neurotransmission in the rat anterior cingulate in effort-related decision making. | Behavioral neuroscience 20051201 |
| Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture. | Molecular and cellular neurosciences 20051201 |
| Reduction in parvalbumin expression in the zona incerta after 6OHDA lesion in rats. | Journal of neurocytology 20051201 |
| l-DOPA administration enhances 6-hydroxydopamine generation. | Brain research 20051130 |
| Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats. | Neuroscience letters 20051125 |
| Deprenyl enhances the striatal neuronal damage produced by quinolinic acid. | Brain research. Molecular brain research 20051118 |
| Amburoside A, a glucoside from Amburanacearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity. | Neuroscience letters 20051111 |
| Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function. | Molecular pharmacology 20051101 |
| CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. | Journal of neurochemistry 20051101 |
| Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats. | Journal of neurochemistry 20051101 |
| Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. | Biochemical pharmacology 20051101 |
| Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems. | Journal of neuroscience research 20051101 |
| Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients? | Anatomy and embryology 20051101 |
| Gene expression profiles of reactive astrocytes cultured from dopamine-depleted striatum. | Neurobiology of disease 20051101 |
| Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats. | Journal of neuropathology and experimental neurology 20051101 |
| Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat. | The European journal of neuroscience 20051101 |
| Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. | European journal of cell biology 20051101 |
| Neuroprotective effect of D-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells. | Journal of bioscience and bioengineering 20051101 |
| Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats. | Neuroscience letters 20051028 |
| The change of the neuron-glia differentiation rate in human neural precursor cells (HPCs) and Ad-BDNF-/-GDNF-infected HPCs following the administration of a neurotoxin. | Neuroscience letters 20051021 |
| Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations. | Journal of neuroscience methods 20051015 |
| Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro. | Neurotoxicology 20051001 |
| Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons. | Synapse (New York, N.Y.) 20051001 |
| Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage. | Journal of neurochemistry 20051001 |
| Anti-apoptotic activity of Bak Foong Pills and its ingredients on 6-hydroxydopamine-induced neurotoxicity in PC12 cells. | Cell biology international 20051001 |
| Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition. | Journal of neurochemistry 20051001 |
| Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease. | The European journal of neuroscience 20051001 |
| Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. | Free radical research 20051001 |
| Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's. | Brain research 20050928 |
| Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria. | The Journal of biological chemistry 20050916 |
| Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. | Journal of neuroscience research 20050915 |
| Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats. | Journal of neural transmission (Vienna, Austria : 1996) 20050901 |
| Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder. | The international journal of neuropsychopharmacology 20050901 |
| Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. | Experimental neurology 20050901 |
| Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways. | Experimental brain research 20050901 |
| Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro. | Toxicological sciences : an official journal of the Society of Toxicology 20050901 |
| Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958. | Neuropharmacology 20050901 |
| Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. | Free radical biology & medicine 20050901 |
| Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats. | Peptides 20050901 |
| The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation. | Anesthesia and analgesia 20050901 |
| Involvement of supraspinal imidazoline receptors and descending monoaminergic pathways in tizanidine-induced inhibition of rat spinal reflexes. | Journal of pharmacological sciences 20050901 |
| Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats. | Analytical and bioanalytical chemistry 20050901 |
| Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats. | Anatomy and embryology 20050901 |
| Neurorescue effects of VEGF on a rat model of Parkinson's disease. | Brain research 20050816 |
| Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. | Brain research 20050809 |
| Adaptation to hydrogen peroxide enhances PC12 cell tolerance against oxidative damage. | Neuroscience letters 20050805 |
| Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. | Brain research 20050802 |
| Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy). | Journal of neural transmission (Vienna, Austria : 1996) 20050801 |
| Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. | Neuroscience letters 20050801 |
| Neuronal markers expression of NGF-primed bone marrow cells (BMCs) transplanted in the brain of 6-hydroxydopamine and ibotenic acid lesioned littermate mice. | Neuroscience letters 20050801 |
| Chemical sympathectomy inhibits periodontal disease in Fischer 344 rats. | Journal of periodontal research 20050801 |
| Rewarding properties of the stereoisomers of 4-methylaminorex: involvement of the dopamine system. | Pharmacology, biochemistry, and behavior 20050801 |
| A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. | Journal of neurochemistry 20050801 |
| Neuroprotection by crocetin in a hemi-parkinsonian rat model. | Pharmacology, biochemistry, and behavior 20050801 |
| Aging and sympathetic modulation of immune function in Fischer 344 rats: effects of chemical sympathectomy on primary antibody response. | Journal of neuroimmunology 20050801 |
| Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains. | Experimental neurology 20050801 |
| Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat. | Pharmacology, biochemistry, and behavior 20050801 |
| In vivo models of multiple system atrophy. | Movement disorders : official journal of the Movement Disorder Society 20050801 |
| The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis. | The European journal of neuroscience 20050801 |
| Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism. | Behavioural brain research 20050730 |
| Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor. | Brain research bulletin 20050730 |
| Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion. | Brain research 20050727 |
| The anti-inflammatory effect of peripheral bee venom stimulation is mediated by central muscarinic type 2 receptors and activation of sympathetic preganglionic neurons. | Brain research 20050712 |
| Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050706 |
| Sympathetic denervation does not prevent a reduction in fat pad size of rats or mice treated with peripherally administered leptin. | American journal of physiology. Regulatory, integrative and comparative physiology 20050701 |
| Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. | The Journal of biological chemistry 20050701 |
| The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity. | Neuroscience letters 20050701 |
| Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. | Experimental neurology 20050701 |
| Apoptosis and nestin expression in the cortex and cultured astrocytes following 6-OHDA administration. | Neuroscience letters 20050701 |
| Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. | Behavioural brain research 20050701 |
| Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity. | Journal of neuroscience research 20050701 |
| Degeneration of dopaminergic neurons triggers an expression of individual enzymes of dopamine synthesis in non-dopaminergic neurons of the arcuate nucleus in adult rats. | Journal of chemical neuroanatomy 20050701 |
| 6-Hydroxydopamine-induced glutathione alteration occurs via glutathione enzyme system in primary cultured astrocytes. | Acta pharmacologica Sinica 20050701 |
| Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro. | Neurological research 20050701 |
| Toxin-induced models of Parkinson's disease. | NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 20050701 |
| Diminished serotonergic innervation of adult medial prefrontal cortex after 6-OHDA lesions in the newborn rat. | Brain research. Developmental brain research 20050630 |
| Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats. | Neuroscience letters 20050624 |
| Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain. | The Journal of comparative neurology 20050613 |
| In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system. | Brain research. Molecular brain research 20050613 |
| Effects of phencyclidine on schedule-controlled responding following neurotoxic lesions of the striatum. | Life sciences 20050610 |
| Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat. | Journal of neural transmission (Vienna, Austria : 1996) 20050601 |
| Arachidonic acid incorporation and turnover is decreased in sympathetically denervated rat heart. | American journal of physiology. Heart and circulatory physiology 20050601 |
| Increase of GAP-43 in the rat cerebellum following unilateral striatal 6-OHDA lesion. | Synapse (New York, N.Y.) 20050601 |
| Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. | Toxicology in vitro : an international journal published in association with BIBRA 20050601 |
| Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease? | Neuropharmacology 20050601 |
| Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. | Experimental neurology 20050601 |
| Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus. | Experimental neurology 20050601 |
| Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease. | Journal of neuroscience research 20050601 |
| PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning. | Cardiovascular research 20050601 |
| The vulnerability of striatal projection neurons and interneurons to excitotoxicity is differentially regulated by dopamine during development. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20050601 |
| Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice. | Journal of pharmacological sciences 20050601 |
| Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20050601 |
| The effects of neurochemical lesioning of dopaminergic terminals in early ontogenesis on behavior in adult rats. | Neuroscience and behavioral physiology 20050601 |
| Receptor binding occurrence and plasma levels of natriuretic peptides in response to sympathectomy. | Microscopy research and technique 20050601 |
| The mechanisms of 6-hydroxydopamine-induced astrocyte death. | Annals of the New York Academy of Sciences 20050601 |
| Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: histological characterization of the grafted cells. | Brain research 20050531 |
| Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats. | Brain research 20050531 |
| Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys. | Behavioural brain research 20050528 |
| Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050518 |
| Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050518 |
| Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. | Journal of neuroscience methods 20050515 |
| 8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease. | Neuroreport 20050512 |
| Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats. | Brain research. Developmental brain research 20050512 |
| The therapeutic effects of dopamine replacement therapy and its psychiatric side effects are mediated by pineal function. | Behavioural brain research 20050507 |
| Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. | The Journal of biological chemistry 20050506 |
| Control of cellular pattern formation in the vertebrate inner retina by homotypic regulation of cell-fate decisions. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050504 |
| Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation. | Neuroscience research 20050501 |
| Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. | Journal of neurochemistry 20050501 |
| Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. | Brain research. Brain research protocols 20050501 |
| Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. | The Journal of comparative neurology 20050418 |
| Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. | Journal of neuroscience methods 20050415 |
| Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats. | Behavioural brain research 20050415 |
| Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050413 |
| Role of amygdalo-nigral circuitry in conditioning of a visual stimulus paired with food. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050413 |
| Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050401 |
| Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats. | Synapse (New York, N.Y.) 20050401 |
| Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050401 |
| Synaptosomal dopamine uptake in rat striatum following controlled cortical impact. | Journal of neuroscience research 20050401 |
| Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. | Journal of neurochemistry 20050401 |
| Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine. | Journal of neurochemistry 20050401 |
| Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease. | Stem cells (Dayton, Ohio) 20050401 |
| Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools. | The International journal of neuroscience 20050401 |
| Glial bFGF and S100 immunoreactivities increase in ascending dopamine pathways following striatal 6-OHDA-induced partial lesion of the nigrostriatal system: a sterological analysis. | The International journal of neuroscience 20050401 |
| The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959. | Pharmacology, biochemistry, and behavior 20050401 |
| Selective effects of partial striatal 6-OHDA lesions on information processing in the rat. | The European journal of neuroscience 20050401 |
| Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study. | The European journal of neuroscience 20050401 |
| Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate. | Physiology & behavior 20050331 |
| Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats. | Behavioural brain research 20050330 |
| Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw. | European journal of pharmacology 20050328 |
| Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity. | Life sciences 20050325 |
| Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. | Brain research. Molecular brain research 20050324 |
| Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion. | Brain research 20050321 |
| Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050316 |
| p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. | Journal of neuroscience research 20050315 |
| The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model. | Brain research 20050315 |
| Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells. | Brain research 20050315 |
| Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production. | Cytokine 20050307 |
| Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease. | Experimental brain research 20050301 |
| Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors. | The Journal of pharmacology and experimental therapeutics 20050301 |
| 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy. | Synapse (New York, N.Y.) 20050301 |
| Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage. | Journal of chemical neuroanatomy 20050301 |
| Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats. | Experimental neurology 20050301 |
| 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging. | Experimental neurology 20050301 |
| Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease. | Neuroscience research 20050301 |
| Re-evaluation and quantification of the different sources of nerve fibres supplying the rat eye. | Journal of anatomy 20050301 |
| Does proteasome [corrected] inhibition decrease or accelerate toxin-induced dopaminergic neurodegeneration? | Journal of pharmacological sciences 20050301 |
| Caffeine and the dopaminergic system. | Behavioural pharmacology 20050301 |
| Proteasome function and pathological proteins in the pathogenesis of Parkinson's disease. | Journal of pharmacological sciences 20050301 |
| Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. | The European journal of neuroscience 20050301 |
| Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. | The European journal of neuroscience 20050301 |
| The effects of 6-hydroxydopamine on the electrical characteristics of snail neurons in long-term sensitization. | Neuroscience and behavioral physiology 20050301 |
| Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. | Human & experimental toxicology 20050301 |
| Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. | Neurochemical research 20050301 |
| Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation. | Brain research 20050221 |
| Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells. | Biochemical and biophysical research communications 20050218 |
| Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats. | Regulatory peptides 20050215 |
| Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease. | Brain research 20050209 |
| Dopamine depletion alters responses to glutamate and GABA in the rat subthalamic nucleus. | Neuroreport 20050208 |
| Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins. | Brain research 20050208 |
| Effects of repeated cocaine on the release and clearance of dopamine within the rat medial prefrontal cortex. | Synapse (New York, N.Y.) 20050201 |
| Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy). | Acta neuropathologica 20050201 |
| A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo. | Experimental neurology 20050201 |
| Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain. | Gut 20050201 |
| Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic (13)C NMS study in the rat. | Experimental neurology 20050201 |
| Testing forelimb placing 'across the midline' reveals distinct, lesion-dependent patterns of recovery in rats. | Experimental neurology 20050201 |
| Analysis of gene expression changes in a cellular model of Parkinson disease. | Neurobiology of disease 20050201 |
| RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells. | Neurobiology of disease 20050201 |
| Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. | Neurobiology of disease 20050201 |
| Effects of intrathecal 6-hydroxydopamine, alpha1 and alpha2 adrenergic receptor antagonists on antinociception of propofol in mice. | Acta pharmacologica Sinica 20050201 |
| Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists. | Bioorganic & medicinal chemistry letters 20050201 |
| Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinson's disease. | Journal of mass spectrometry : JMS 20050201 |
| The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. | Brain research. Brain research reviews 20050201 |
| 6-Hydroxydopamine lesions in female hamsters (Mesocricetus auratus) abolish the sensitized effects of sexual experience on copulatory interactions with males. | Behavioral neuroscience 20050201 |
| A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease. | The European journal of neuroscience 20050201 |
| An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. | Behavioural brain research 20050130 |
| Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050126 |
| Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline. | Brain research 20050125 |
| Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model. | Neuroscience letters 20050120 |
| Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat. | Synapse (New York, N.Y.) 20050101 |
| Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro. | Neurotoxicology 20050101 |
| The conditioned enhancement of neutrophil activity is catecholamine dependent. | Journal of neuroimmunology 20050101 |
| Bilateral nigral 6-hydroxydopamine lesions increase the amount of extracellular dopamine in the nucleus accumbens. | Experimental neurology 20050101 |
| The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons. | Experimental neurology 20050101 |
| Morphology and distribution of dopaminergic neurons intrinsic to the human striatum. | Journal of chemical neuroanatomy 20050101 |
| Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice. | Neuroscience research 20050101 |
| Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours. | The European journal of neuroscience 20050101 |
| Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. | Journal of neurosurgery 20050101 |
| Specific pathophysiological functions of JNK isoforms in the brain. | The European journal of neuroscience 20050101 |
| [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus]. | Revista de neurologia 20050101 |
| Aminopeptidase activity in the nigrostriatal system and prefrontal cortex of rats with experimental hemiparkinsonism. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20050101 |
| Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions. | Neuroscience 20050101 |
| Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog. | Neuroscience 20050101 |
| Bilateral increase of perforated synapses after unilateral dopamine depletion. | The International journal of neuroscience 20050101 |
| Transient and widespread astroglial activation in the brain after a striatal 6-OHDA-induced partial lesion of the nigrostriatal system. | The International journal of neuroscience 20050101 |
| Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats. | Journal of proteome research 20050101 |
| Coherent spike-wave oscillations in the cortex and subthalamic nucleus of the freely moving rat. | Neuroscience 20050101 |
| Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. | Neuroscience 20050101 |
| Comparative effects of acute or chronic administration of levodopa to 6-hydroxydopamine-lesioned rats on the expression of glutamic acid decarboxylase in the neostriatum and GABAA receptors subunits in the substantia nigra, pars reticulata. | Neuroscience 20050101 |
| Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. | Neurobiology of disease 20050101 |
| Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. | Neuroscience 20050101 |
| Increased splenocyte mitogenesis following sympathetic denervation in Xenopus laevis. | Developmental and comparative immunology 20050101 |
| Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes. | Neuroscience 20050101 |
| Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. | Antioxidants & redox signaling 20050101 |
| Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue. | Neuroscience 20050101 |
| Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. | Neuroscience 20050101 |
| Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease. | Redox report : communications in free radical research 20050101 |
| Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats. | Neuroscience 20050101 |
| Alterations in the proportions of skeletal muscle proteins following a unilateral lesion to the substantia nigra pars compacta of rats. | Journal of muscle research and cell motility 20050101 |
| Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro. | Clinical neuropharmacology 20050101 |
| Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats. | Neuroscience 20050101 |
| Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. | Neurochemical research 20050101 |
| Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood. | Neuroscience 20050101 |
| Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model. | Surgical neurology 20050101 |
| Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity. | BMC neuroscience 20050101 |
| In vivo PET measurements with [11C]PE2I to evaluate fetal mesencephalic transplantations to unilateral 6-OHDA-lesioned rats. | Cell transplantation 20050101 |
| JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. | The Journal of biological chemistry 20041231 |
| Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats. | Regulatory peptides 20041215 |
| Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord. | Regulatory peptides 20041215 |
| Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: a study inspired by the physiological roles of PACAP in the brain. | Regulatory peptides 20041215 |
| Biphasic effects of oxotremorine-M on turning behavior induced by caffeine in 6-OHDA-lesioned rats. | European journal of pharmacology 20041203 |
| The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity. | Toxicology letters 20041201 |
| Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway. | British journal of pharmacology 20041201 |
| The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20041201 |
| Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor. | The European journal of neuroscience 20041201 |
| Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures. | Journal of neurochemistry 20041201 |
| Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus. | The European journal of neuroscience 20041201 |
| Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with L-DOPA: implication for L-DOPA-induced dyskinesia in Parkinson's disease. | Neuropathology : official journal of the Japanese Society of Neuropathology 20041201 |
| Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. | Neurochemical research 20041201 |
| [Iptakalim enhances astrocytic glutamate uptake activity]. | Yao xue xue bao = Acta pharmaceutica Sinica 20041201 |
| The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells. | Neuroscience letters 20041123 |
| Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. | The Journal of biological chemistry 20041119 |
| Effect of 17-beta-estradiol on dopamine, serotonine and GABA striatal levels in 6-hydroxydopamine-treated rats. | Toxicology 20041115 |
| Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease. | Brain research 20041105 |
| Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease. | Brain research 20041105 |
| Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. | British journal of pharmacology 20041101 |
| Purinergic modulation of extracellular glutamate levels in the nucleus accumbens in vivo. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20041101 |
| Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons. | Neurobiology of disease 20041101 |
| Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat. | Naunyn-Schmiedeberg's archives of pharmacology 20041101 |
| Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor. | Pharmacology, biochemistry, and behavior 20041101 |
| Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine. | Journal of neuroscience research 20041015 |
| Role of catecholaminergic inputs to the medial prefrontal cortex in local and subcortical expression of Fos after psychological stress. | Journal of neuroscience research 20041015 |
| Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis. | Journal of neuroscience research 20041015 |
| Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20041013 |
| Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence. | Behavioural brain research 20041005 |
| Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats. | Behavioural brain research 20041005 |
| Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041001 |
| Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. | Brain research 20041001 |
| Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions. | Journal of neurochemistry 20041001 |
| Deficits in a lateralized associative learning task in dopamine-depleted rats with functional recovery by dopamine-rich transplants. | The European journal of neuroscience 20041001 |
| Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease. | Journal of neurochemistry 20041001 |
| Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. | Cell and tissue research 20041001 |
| Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant. | Biochemical and biophysical research communications 20040924 |
| Effect of central thyrotropin-releasing hormone on pancreatic blood flow in rats. | Regulatory peptides 20040915 |
| Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test. | Physiology & behavior 20040915 |
| 6-hydroxydopamine lesions in anuran amphibians: a new model system for Parkinson's disease? | Journal of neurobiology 20040915 |
| Co-treatment with ethanol enhances the toxicity of 6-hydroxydopamine. | Neuroscience letters 20040902 |
| Effects of orbital prefrontal cortex dopamine depletion on inter-temporal choice: a quantitative analysis. | Psychopharmacology 20040901 |
| NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats. | Psychopharmacology 20040901 |
| Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport. | Archives of toxicology 20040901 |
| SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. | The Journal of pharmacology and experimental therapeutics 20040901 |
| Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine. | Experimental neurology 20040901 |
| Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration. | Molecular therapy : the journal of the American Society of Gene Therapy 20040901 |
| Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system. | Journal of neurochemistry 20040901 |
| 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. | Journal of neuroscience research 20040901 |
| Cholecystokinin tetrapeptide improves water maze performance of neonatally 6-hydroxydopamine-lesioned young rats. | Pharmacology, biochemistry, and behavior 20040901 |
| Neuroprotective effects of the antiparkinson drug Mucuna pruriens. | Phytotherapy research : PTR 20040901 |
| Effect of 6-hydroxydopamine on the gene expression of Na+/Ca2+ exchanger in the rat heart. | General physiology and biophysics 20040901 |
| Serial induction of mutations by ethylnitrosourea in PC12 cells: a new model for a phenotypical characterization of the neurotoxic response to 6-hydroxydopamine. | Journal of neuroscience methods 20040830 |
| Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease. | Brain research bulletin 20040830 |
| New insights into iron release from ferritin: direct observation of the neurotoxin 6-hydroxydopamine entering ferritin and reaching redox equilibrium with the iron core. | Organic & biomolecular chemistry 20040821 |
| Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. | Regulatory peptides 20040815 |
| Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis. | Cancer research 20040815 |
| Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat. | Brain research 20040806 |
| Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20040804 |
| Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040801 |
| Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism. | The Journal of pharmacology and experimental therapeutics 20040801 |
| Immobilization induces acute nitric oxide production in the rat hypothalamus: a role of ionotropic glutamate receptors in the paraventricular nucleus. | Endocrinology 20040801 |
| NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats. | Neuropharmacology 20040801 |
| Increased dopamine release in vivo by estradiol benzoate from the central amygdaloid nucleus of Parkinson's disease model rats. | Journal of neurochemistry 20040801 |
| Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells. | Neurobiology of disease 20040801 |
| The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system. | Journal of neuroimmunology 20040801 |
| Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats. | Neurosurgery 20040801 |
| Bystin as a novel marker for reactive astrocytes in the adult rat brain following injury. | The European journal of neuroscience 20040801 |
| Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation. | The European journal of neuroscience 20040801 |
| [Stromal cell transplant in the 6-OHDA lesion model]. | Revista de neurologia 20040801 |
| Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease. | Phytotherapy research : PTR 20040801 |
| Opposite morphological responses of partially denervated cortical serotonergic and noradrenergic axons to repeated stress in adult rats. | Brain research bulletin 20040730 |
| N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. | Neuroreport 20040719 |
| Lesions of the dorsal noradrenergic bundle augment the renin response to blood loss but do not alter hypothalamic Fos expression. | Brain research bulletin 20040715 |
| Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias. | Behavioural brain research 20040709 |
| High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions. | Brain research 20040702 |
| The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. | Molecular psychiatry 20040701 |
| Selective knockdown of gene expression of N-methyl-D-aspartate receptor one ameliorates parkinsonian motor symptom in 6-hydroxydopamine-lesioned rats. | Neurochemistry international 20040701 |
| Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040701 |
| Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. | Brain : a journal of neurology 20040701 |
| Rasagiline enhances L-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig. | Neuropharmacology 20040701 |
| The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. | Experimental neurology 20040701 |
| Dopamine depletion impairs precursor cell proliferation in Parkinson disease. | Nature neuroscience 20040701 |
| In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats. | Journal of neurochemistry 20040701 |
| Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone. | The European journal of neuroscience 20040701 |
| Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. | Molecular therapy : the journal of the American Society of Gene Therapy 20040701 |
| Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. | Pharmacology, biochemistry, and behavior 20040701 |
| Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions. | Movement disorders : official journal of the Movement Disorder Society 20040701 |
| Peripheral P2X receptors and nociception: interactions with biogenic amine systems. | Pain 20040701 |
| Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. | Pain 20040701 |
| Gene expression profiles of reactive astrocytes in dopamine-depleted striatum. | Brain pathology (Zurich, Switzerland) 20040701 |
| Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20040630 |
| Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA. | Brain research 20040625 |
| Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20040609 |
| Beneficial effects of intraventricularly administered BMP-7 following a striatal 6-hydroxydopamine lesion. | Brain research 20040604 |
| Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040601 |
| Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA. | Synapse (New York, N.Y.) 20040601 |
| The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action? | Naunyn-Schmiedeberg's archives of pharmacology 20040601 |
| Change in phase synchronization of local field potentials in anesthetized rats after chronic dopamine depletion. | Neuroscience research 20040601 |
| The role of NF-kappaB in 6-hydroxydopamine- and TNFalpha-induced apoptosis of PC12 cells. | Naunyn-Schmiedeberg's archives of pharmacology 20040601 |
| Increased norepinephrine production associated with burn injuries results in CCL2 production and type 2 T cell generation. | Burns : journal of the International Society for Burn Injuries 20040601 |
| Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity. | Journal of neural transmission (Vienna, Austria : 1996) 20040601 |
| A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. | Neurobiology of disease 20040601 |
| Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle. | Metabolic brain disease 20040601 |
| Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats. | Neuroscience letters 20040520 |
| Extracellular taurine in the substantia nigra: taurine-glutamate interaction. | Journal of neuroscience research 20040515 |
| Clozapine prolongs hypotonic immobility in rats with bilateral 6-hydroxydopamine lesions of the striatum. | Neuroscience letters 20040513 |
| Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. | The Journal of biological chemistry 20040507 |
| Cognitive inflexibility after prefrontal serotonin depletion. | Science (New York, N.Y.) 20040507 |
| Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements. | Behavioural brain research 20040505 |
| Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. | Behavioural brain research 20040505 |
| Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease. | Behavioural brain research 20040505 |
| Dopaminergic agonists and muscarinic antagonists improve lateralization in hemiparkinsonian rats in a novel exploratory Y-maze. | The Journal of pharmacology and experimental therapeutics 20040501 |
| L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease. | Synapse (New York, N.Y.) 20040501 |
| An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality. | Experimental neurology 20040501 |
| Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. | Experimental neurology 20040501 |
| Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease. | Experimental neurology 20040501 |
| Slow N-acetyltransferase 2 status leads to enhanced intrastriatal dopamine depletion in 6-hydroxydopamine-lesioned rats. | Experimental neurology 20040501 |
| Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. | Journal of neurochemistry 20040501 |
| Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system. | The European journal of neuroscience 20040501 |
| Pedunculopontine nucleus. | Journal of neurosurgery 20040501 |
| The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. | The Journal of pharmacy and pharmacology 20040501 |
| Survival and migration of transplanted neural stem cell-derived dopamine cells in the brain of parkinsonian rat. | The International journal of neuroscience 20040501 |
| Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. | Neuroscience letters 20040429 |
| The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro. | Brain research 20040409 |
| Dissociation of hemi-spatial and hemi-motor impairments in a unilateral primate model of Parkinson's disease. | Behavioural brain research 20040402 |
| A hypothalamic-testicular neural pathway is influenced by brain catecholamines, but not testicular blood flow. | Endocrinology 20040401 |
| Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. | The international journal of biochemistry & cell biology 20040401 |
| Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function. | Experimental neurology 20040401 |
| Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. | Journal of neurochemistry 20040401 |
| Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. | Human gene therapy 20040401 |
| Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. | Journal of neurosurgery 20040401 |
| [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040401 |
| Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20040324 |
| Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats. | Neuroscience letters 20040318 |
| Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice. | Synapse (New York, N.Y.) 20040315 |
| Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations. | Synapse (New York, N.Y.) 20040315 |
| Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion. | Synapse (New York, N.Y.) 20040301 |
| High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040301 |
| Participation of the substantia nigra dopaminergic neurons in the occurrence of gastric mucosal erosions. | Physiology & behavior 20040301 |
| Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. | The European journal of neuroscience 20040301 |
| Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease. | Neuroreport 20040301 |
| Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. | Annals of the New York Academy of Sciences 20040301 |
| Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions. | Journal of neurocytology 20040301 |
| Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats. | Neuroscience letters 20040226 |
| Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease. | European journal of pharmacology 20040220 |
| Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease. | Neuroscience letters 20040219 |
| Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. | Current biology : CB 20040217 |
| [Therapeutic study of autologous Schwann cells' bridge graft into the brain of hemiparkinsonian monkey]. | Zhonghua yi xue za zhi 20040217 |
| Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates. | Psychopharmacology 20040201 |
| Locally released norepinephrine in the oxygen-dependent regulation of vascular tone of human umbilical vein. | Pediatric research 20040201 |
| Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease. | Biomaterials 20040201 |
| Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease. | Synapse (New York, N.Y.) 20040201 |
| Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats. | Synapse (New York, N.Y.) 20040201 |
| Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. | Neuropharmacology 20040201 |
| Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine. | The International journal of neuroscience 20040201 |
| Sympathetic nervous system regulation of immunity. | Journal of neuroimmunology 20040201 |
| Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor. | Pharmacology, biochemistry, and behavior 20040201 |
| Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. | Journal of neurochemistry 20040201 |
| Vulnerabilities of ventral mesencephalic neurons projecting to the nucleus accumbens following infusions of 6-hydroxydopamine into the medial forebrain bundle in the rat. | Brain research 20040130 |
| 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. | Brain research 20040123 |
| Ventral striatopallidal oxytocin and vasopressin V1a receptors in the monogamous prairie vole (Microtus ochrogaster). | The Journal of comparative neurology 20040119 |
| Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment. | Neurology 20040113 |
| Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040101 |
| Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry. | Experimental brain research 20040101 |
| 'Hydrocephalus-parkinsonism complex': progressive hydrocephalus as a factor affecting extrapyramidal tract disorder-an experimental study. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20040101 |
| Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa. | Neuroscience 20040101 |
| Neuritogenic and survival-promoting effects of the P2 peptide derived from a homophilic binding site in the neural cell adhesion molecule. | Journal of neuroscience research 20040101 |
| Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. | Journal of neuroscience research 20040101 |
| Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | Journal of neurochemistry 20040101 |
| CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine. | Journal of neurochemistry 20040101 |
| Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia. | Experimental neurology 20040101 |
| Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. | Molecular pharmacology 20040101 |
| Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia. | Journal of neuropathology and experimental neurology 20040101 |
| [Modeling Parkinson's disease and objectifying the nigro-striatum system dysfunction]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101 |
| Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. | Neuroscience 20040101 |
| The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease. | Reviews in the neurosciences 20040101 |
| Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. | Journal of proteome research 20040101 |
| Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration. | Stem cells (Dayton, Ohio) 20040101 |
| Liposomal formulations of tacrolimus and rapamycin increase graft survival and fiber outgrowth of dopaminergic grafts. | Cell transplantation 20040101 |
| Comparison of embryonic stem cell-derived dopamine neuron grafts and fetal ventral mesencephalic tissue grafts: morphology and function. | Cell transplantation 20040101 |
| Fate of (D-Ala2)-deltorphin-I-like immunoreactive neurons in 6-hydroxydopamine lesioned rat brain. | European journal of histochemistry : EJH 20040101 |
| Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease. | Neuroscience 20040101 |
| Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats. | Neural plasticity 20040101 |
| The potential role of vascular endothelial growth factor in the central nervous system. | Reviews in the neurosciences 20040101 |
| Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. | Neurotoxicity research 20040101 |
| Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo. | Cell transplantation 20040101 |
| FGF-2 and S100beta immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA-induced partial lesion of the nigrostriatal system. | Cell biology international 20040101 |
| Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. | Stem cells (Dayton, Ohio) 20040101 |
| AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation. | Critical reviews in neurobiology 20040101 |
| Plasma aminopeptidase activities in rats after left and right intrastriatal administration of 6-hydroxydopamine. | Neuroendocrinology 20040101 |
| Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. | Journal of molecular neuroscience : MN 20040101 |
| Origin and mediation of secretion induced by oral phytohaemagglutinin (PHA) in rats. | Acta physiologica Hungarica 20040101 |
| Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats. | Neuro-degenerative diseases 20040101 |
| Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. | Brain research 20031219 |
| Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. | Neuroscience letters 20031219 |
| Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice. | Synapse (New York, N.Y.) 20031215 |
| Baculovirus p35 gene greatly enhances PC12 cell's resistance against oxidative stress. | Journal of the neurological sciences 20031215 |
| Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase. | Brain research bulletin 20031215 |
| Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. | Neurology 20031209 |
| Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease. | Neurology 20031209 |
| Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease. | Neurology 20031209 |
| Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion. | Neurochemistry international 20031201 |
| 'Passive stabilization' of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. | Journal of neurochemistry 20031201 |
| Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process. | Neuroscience research 20031201 |
| Dopamine receptor supersensitivity in rat subthalamus after 6-hydroxydopamine lesions. | The European journal of neuroscience 20031201 |
| Neurochemical correlates of sparing from motor deficits in rats depleted of striatal dopamine as weanlings. | Developmental psychobiology 20031201 |
| [Relationship between neurotoxicity of 6-hydroxydopamine and glutamate transport]. | Yao xue xue bao = Acta pharmaceutica Sinica 20031201 |
| The role of metallothionein II in neuronal differentiation and survival. | Brain research 20031128 |
| Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxydopamine. | Neuroscience letters 20031127 |
| Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. | Brain research. Molecular brain research 20031126 |
| A unilateral 6-hydroxydopamine lesion decreases the expression of metabotropic glutamate receptors in rat substantia nigra. | Neuroscience letters 20031120 |
| Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells. | Journal of the neurological sciences 20031115 |
| Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons. | Brain research 20031107 |
| The importance of the prolonged postnatal period in determination of heart atrial muscarinic receptor and beta-adrenoceptor densities. | Life sciences 20031107 |
| Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy. | American journal of physiology. Endocrinology and metabolism 20031101 |
| Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats. | Synapse (New York, N.Y.) 20031101 |
| Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats. | Synapse (New York, N.Y.) 20031101 |
| Role of brain dopaminergic system in the adrenomedullin-induced diuresis and natriuresis. | Pharmacological research 20031101 |
| The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release? | Anesthesia and analgesia 20031101 |
| Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regeneration. | Experimental neurology 20031101 |
| mGluRs: a target for pharmacotherapy in Parkinson disease. | Experimental neurology 20031101 |
| Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20031101 |
| Chemical sympathectomy by 6-OH dopamine during fetal life results in inguinal testis through altering cremasteric contractility in rats. | Journal of pediatric surgery 20031101 |
| Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. | The European journal of neuroscience 20031101 |
| Can the brain be protected through exercise? Lessons from an animal model of parkinsonism. | Experimental neurology 20031101 |
| Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. | Experimental neurology 20031101 |
| Interaction between serotonergic and noradrenergic axons during axonal regeneration. | Experimental neurology 20031101 |
| A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. | Experimental neurology 20031101 |
| Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus). | Experimental neurology 20031101 |
| Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse. | Journal of pharmacological sciences 20031101 |
| [Wakefulness and central basal nuclei: experimental observations and possible implications in Parkinson's disease]. | Revue neurologique 20031101 |
| Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. | The European journal of neuroscience 20031101 |
| [The effect of neurochemical damage of dopaminergic terminals in early ontogenesis on the behavior of adult rats]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20031101 |
| Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception. | Brain research 20031017 |
| Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat. | Brain research. Molecular brain research 20031007 |
| Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine. | Brain research 20031003 |
| Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031001 |
| Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons. | Neurobiology of disease 20031001 |
| Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. | Biochemical pharmacology 20031001 |
| Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells. | Cellular and molecular neurobiology 20031001 |
| Dopaminergic trophism after intrastriatal injection of lentivirus-transferred GDNF in Parkinson rat model. | Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica 20031001 |
| Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20031001 |
| Primate models of Parkinson's disease. | Experimental neurology 20031001 |
| Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra. | Experimental neurology 20031001 |
| Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys. | Experimental neurology 20031001 |
| Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats. | Experimental neurology 20031001 |
| Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20031001 |
| Effect of ipsilateral subthalamic nucleus lesioning in a rat parkinsonian model: study of behavior correlated with neuronal activity in the pedunculopontine nucleus. | Journal of neurosurgery 20031001 |
| Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. | Journal of chemical neuroanatomy 20031001 |
| Effect of 6-OHDA lesions of the dopaminergic mesolimbic system on drug priming induced reinstatement of extinguished morphine CPP in rats. | Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20031001 |
| Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic-cholinergic interaction. | Brain research bulletin 20030930 |
| Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease. | The Journal of biological chemistry 20030926 |
| Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion. | Synapse (New York, N.Y.) 20030915 |
| Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity. | Journal of medicinal chemistry 20030911 |
| Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030910 |
| High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats. | Brain research 20030905 |
| The meningeal sheath of the regenerating spinal cord of the eel, Anguilla. | Anatomy and embryology 20030901 |
| In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria. | American journal of physiology. Endocrinology and metabolism 20030901 |
| Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat. | Journal of neuroscience research 20030901 |
| Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. | Hepatology (Baltimore, Md.) 20030901 |
| Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats. | Journal of neurochemistry 20030901 |
| Transfer of the von Hippel-Lindau gene to neuronal progenitor cells in treatment for Parkinson's disease. | Annals of neurology 20030901 |
| Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat. | The European journal of neuroscience 20030901 |
| Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa. | Experimental neurology 20030901 |
| Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. | Experimental neurology 20030901 |
| Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. | The European journal of neuroscience 20030901 |
| [Effect of 6-hydroxydopamine on the electrical characteristics of snail neurons in long-term sensitization]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20030901 |
| Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030827 |
| [Correlation between iron levels and degeneration of dopaminergic neurons in rat nigrostriatal system during the early 6-OHDA lesions in medial forebrain bundle]. | Sheng li xue bao : [Acta physiologica Sinica] 20030825 |
| Role of the mesotelencephalic dopamine system in learning and memory processes in the rat. | European journal of pharmacology 20030815 |
| In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells. | Human gene therapy 20030810 |
| Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. | British journal of pharmacology 20030802 |
| LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. | The Journal of pharmacology and experimental therapeutics 20030801 |
| Toluene-induced locomotor activity is blocked by 6-hydroxydopamine lesions of the nucleus accumbens and the mGluR2/3 agonist LY379268. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030801 |
| Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. | Brain research 20030801 |
| Central catecholamine depletion inhibits peripheral lymphocyte responsiveness in spleen and blood. | Journal of neurochemistry 20030801 |
| The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. | Pharmacology & toxicology 20030801 |
| Behavioral correction of Parkinsonian rats following the transplantation of immortalized fibroblasts genetically modified with TH and GCH genes. | Parkinsonism & related disorders 20030801 |
| The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis. | The European journal of neuroscience 20030801 |
| High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task. | The European journal of neuroscience 20030801 |
| Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030716 |
| Neurotrophic factor in the treatment of Parkinson disease. | Neurosurgical focus 20030715 |
| Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease. | Experimental brain research 20030701 |
| Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. | Journal of neurochemistry 20030701 |
| Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent? | Journal of neural transmission (Vienna, Austria : 1996) 20030701 |
| Models of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20030701 |
| Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. | Journal of neuroscience research 20030701 |
| Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats. | Journal of hepatology 20030701 |
| Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. | Pharmacology & toxicology 20030701 |
| Group I mGluR ligands fail to affect 6-hydroxydopamine- induced death and glutamate release of PC12 cells. | Acta pharmacologica Sinica 20030701 |
| Firing regulation in dopaminergic cells: effect of the partial degeneration of nigrostriatal system in surviving neurons. | The European journal of neuroscience 20030701 |
| The role of the sympathetic nervous system in moxibustion-induced immunomodulation in rats. | Journal of neuroimmunology 20030701 |
| Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. | Journal of neurochemistry 20030701 |
| Acute alcohol administration improves skilled reaching success in intact but not 6-OHDA dopamine depleted rats: a subsystems analysis of the motoric and anxiolytic effects of alcohol. | Behavioural brain research 20030616 |
| Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats. | Journal of neuroscience research 20030615 |
| Distinct forelimb and hind limb stepping impairments in unilateral dopamine-depleted rats: use of the rotorod as a method for the qualitative analysis of skilled walking. | Journal of neuroscience methods 20030615 |
| Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030615 |
| Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20030601 |
| Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. | The European journal of neuroscience 20030601 |
| The dopaminergic system in attention deficit/hyperactivity disorder. | Congenital anomalies 20030601 |
| Increased p53 levels without caspase-3 activity and change of cell viability in 6-hydroxydopamine-treated CV1-P cells. | Cell biology and toxicology 20030601 |
| Dopamine effect on the stimulus pattern related changes in response characteristics of R/G horizontal cells in carp retina. | Brain research 20030530 |
| Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation. | Neuroscience letters 20030529 |
| Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. | The Journal of biological chemistry 20030523 |
| EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease. | Brain research 20030516 |
| Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats. | Brain research 20030516 |
| Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra. | Synapse (New York, N.Y.) 20030501 |
| A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau. | Neuroscience letters 20030501 |
| Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity. | Journal of neurochemistry 20030501 |
| Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. | Journal of neurochemistry 20030501 |
| Striatal formation of 6-hydroxydopamine in mice treated with pargyline, pyrogallol and methamphetamine. | Journal of neural transmission (Vienna, Austria : 1996) 20030501 |
| Impairment of the renal p-aminohippurate transport induced by 6-hydroxydopamine. | The Journal of pharmacy and pharmacology 20030501 |
| Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. | The Journal of biological chemistry 20030418 |
| Both pineal and lateral eyes are needed to sustain daily circulating melatonin rhythms in sea bass. | Brain research 20030418 |
| Convulsive and postural effects of lesioning the mid-substantia nigra pars reticulata in naïve and 6-hydroxydopamine lesioned rats. | Brain research bulletin 20030415 |
| Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists. | Bioorganic & medicinal chemistry 20030403 |
| Animal models of attention-deficit hyperactivity disorder. | Brain research. Brain research reviews 20030401 |
| Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. | Journal of neurochemistry 20030401 |
| Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector. | Human gene therapy 20030320 |
| Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. | European journal of pharmacology 20030307 |
| Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens. | Journal of neurochemistry 20030301 |
| Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation. | Journal of neurochemistry 20030301 |
| Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia. | Journal of neurochemistry 20030301 |
| Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: different action on GABA cell subpopulations. | Movement disorders : official journal of the Movement Disorder Society 20030301 |
| Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030301 |
| Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET. | European journal of nuclear medicine and molecular imaging 20030301 |
| D2 Dopamine receptor blockade results in sprouting of DA axons in the intact animal but prevents sprouting following nigral lesions. | The European journal of neuroscience 20030301 |
| Spreading of slow cortical rhythms to the basal ganglia output nuclei in rats with nigrostriatal lesions. | The European journal of neuroscience 20030301 |
| Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. | Experimental neurology 20030301 |
| Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats. | The Tohoku journal of experimental medicine 20030301 |
| Neural stem cells. Biological features and therapeutic potential in Parkinson's disease. | Journal of neurosurgical sciences 20030301 |
| [Effects of sympathectomy on the blood pressure of young Wistar rats fed with high-sucrose diet]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20030301 |
| Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons. | Life sciences 20030221 |
| Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat. | Behavioural brain research 20030217 |
| Pathogenic role of glial cells in Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20030201 |
| Catalepsy intensifies context-dependently irrespective of whether it is induced by intermittent or chronic dopamine deficiency. | Behavioural pharmacology 20030201 |
| Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity. | Journal of biosciences 20030201 |
| Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle. | Neuroreport 20030120 |
| Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments. | European journal of pharmacology 20030117 |
| Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonism. | European journal of pharmacology 20030117 |
| A novel skilled-reaching impairment in paw supination on the 'good' side of the hemi-Parkinson rat improved with rehabilitation. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030115 |
| Effects of sex and estrogen on behavioral sensitization to cocaine in rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030115 |
| The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. | Annual review of pharmacology and toxicology 20030101 |
| 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET. | Nuclear medicine communications 20030101 |
| Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta. | Experimental neurology 20030101 |
| Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. | Neuroscience 20030101 |
| Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortical dopamine responses to stress. | Neuroscience 20030101 |
| Effect of 6-hydroxydopamine on gluconeogenesis in the rat renal cortex. | Clinical and experimental pharmacology & physiology 20030101 |
| Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease. | Journal of neurosurgery 20030101 |
| Effects of 6-hydroxydopamine on the development of the immune system in chickens. | The Journal of veterinary medical science 20030101 |
| Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model. | Neuroscience 20030101 |
| Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. | Neuroscience 20030101 |
| Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. | Neuroscience 20030101 |
| Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study. | Neuroscience 20030101 |
| Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment. | Neurotoxicity research 20030101 |
| Neurotrophic factors for the investigation and treatment of movement disorders. | Neurotoxicity research 20030101 |
| Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain. | Neuroscience 20030101 |
| Changes in GABA(B) receptor mRNA expression in the rodent basal ganglia and thalamus following lesion of the nigrostriatal pathway. | Neuroscience 20030101 |
| Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat. | Neuroscience 20030101 |
| Animal models of Parkinson's disease in rodents induced by toxins: an update. | Journal of neural transmission. Supplementum 20030101 |
| Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning. | Journal of neural transmission. Supplementum 20030101 |
| Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20030101 |
| Effect of subthalamic lesion with kainic acid on the neuronal activities of the basal ganglia of rat parkinsonian models with 6-hydroxydopamine. | Acta neurochirurgica. Supplement 20030101 |
| Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion. | Neuroscience 20030101 |
| Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats. | Neuroscience 20030101 |
| Apomorphine attenuates 6-hydroxydopamine-induced apoptotic cell death in SH-SY5Y cells. | Redox report : communications in free radical research 20030101 |
| A6 noradrenergic cell group modulates the hypoxic ventilatory response. | Advances in experimental medicine and biology 20030101 |
| Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. | Neurotoxicity research 20030101 |
| Co-localization of histamine and dopamine-beta-hydroxylase in sympathetic ganglion and release of histamine from cardiac sympathetic terminals of guinea-pig. | Autonomic & autacoid pharmacology 20030101 |
| Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. | The Journal of biological chemistry 20021227 |
| Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats. | Neuroscience letters 20021225 |
| Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat. | Brain research 20021220 |
| Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20021215 |
| Fixed ratio discrimination training increases in vivo striatal dopamine in neonatal 6-OHDA-lesioned rats. | Pharmacology, biochemistry, and behavior 20021201 |
| Locomotor stimulant effects of nornicotine: role of dopamine. | Pharmacology, biochemistry, and behavior 20021201 |
| Diffusion parameters in the striatum of rats with 6-hydroxydopamine-induced lesions and with fetal mesencephalic grafts. | Journal of neuroscience research 20021201 |
| Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. | Brain : a journal of neurology 20021201 |
| Activation of tyrosine hydroxylase in the lateral efferent terminals by sound conditioning. | Hearing research 20021201 |
| Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease. | Molecular pharmacology 20021201 |
| Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20021201 |
| Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. | The American journal of pathology 20021201 |
| Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors. | Stroke 20021201 |
| AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa. | The European journal of neuroscience 20021201 |
| Chemical sympathectomy increases numbers of inflammatory cells in the peritoneum early in murine listeriosis. | Brain, behavior, and immunity 20021201 |
| Contrasting pattern of cytokines in antigen- versus mitogen-stimulated splenocyte cultures from chemically denervated mice. | Brain, behavior, and immunity 20021201 |
| An inflammatory review of Parkinson's disease. | Progress in neurobiology 20021201 |
| Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity. | Brain research 20021129 |
| Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins. | Neuroscience letters 20021115 |
| Acute and repeated treatment with L-DOPA increase c-jun expression in the 6-hydroxydopamine-lesioned forebrain of rats and common marmosets. | Brain research 20021115 |
| [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents. | Brain research 20021108 |
| The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced apoptosis. | The Journal of biological chemistry 20021101 |
| Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra. | Pharmacology, biochemistry, and behavior 20021101 |
| Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors. | Journal of neurochemistry 20021101 |
| Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine. | Journal of neuroimmunology 20021101 |
| Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats. | Movement disorders : official journal of the Movement Disorder Society 20021101 |
| Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors. | Molecular and cellular neurosciences 20021101 |
| Distribution of adenosine A(2A) receptor antagonist KW-6002 and its effect on gene expression in the rat brain. | Brain research 20021025 |
| Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20021015 |
| Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats. | Brain research 20021011 |
| Subthalamic GAD gene therapy in a Parkinson's disease rat model. | Science (New York, N.Y.) 20021011 |
| Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: evidence of lasting reorganization of corticostriatal input. | The Journal of comparative neurology 20021007 |
| Rotational behaviour in AA and ANA rats after repeated administration of morphine and cocaine. | Pharmacology, biochemistry, and behavior 20021001 |
| Effect of glutamatergic systems on in vivo binding of [(125)I]beta-CIT in the brain of a rat model of Parkinson's disease. | Synapse (New York, N.Y.) 20021001 |
| Early, selective, and marked loss of sympathetic nerves from the islets of BioBreeder diabetic rats. | Diabetes 20021001 |
| Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20021001 |
| Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism. | Journal of neural transmission (Vienna, Austria : 1996) 20021001 |
| Rat heart GDNF: effect of chemical sympathectomy. | Histochemistry and cell biology 20021001 |
| PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease. | Neuropharmacology 20021001 |
| Catecholaminergic neuronal degeneration in rainbow trout assessed by skin color change: a model system for identification of environmental risk factors. | Neurotoxicology 20021001 |
| Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. | Experimental neurology 20021001 |
| Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models. | Experimental neurology 20021001 |
| Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors. | Journal of neuroimmunology 20021001 |
| The sympathetic nervous system is involved in the inhibitory effect of morphine on the colon motility in rats. | Autonomic neuroscience : basic & clinical 20020930 |
| Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell-derived inducing activity. | Journal of neuroscience research 20020915 |
| Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. | Journal of neuroscience research 20020915 |
| Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease. | Journal of neurobiology 20020915 |
| The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020915 |
| Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease. | Neuroscience letters 20020913 |
| Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease. | Pharmacology, biochemistry, and behavior 20020901 |
| Effect of FK506 on neurotransmitter content and expression of GAP-43 in neurotoxin-lesioned peripheral sensory and sympathetic neurons. | Pharmacology 20020901 |
| Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum. | The Journal of pharmacology and experimental therapeutics 20020901 |
| Functional and histochemical characterization of a uterine adrenergic denervation process in pregnant rats. | Biology of reproduction 20020901 |
| (123)I- or (125)I-metaiodobenzylguanidine visualization of brown adipose tissue. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020901 |
| alpha2-Adrenoceptors control the release of noradrenaline but not neuropeptide Y from perivascular nerve terminals. | Peptides 20020901 |
| Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? | Parkinsonism & related disorders 20020901 |
| Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid aspirin. | Parkinsonism & related disorders 20020901 |
| Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells. | Neuropharmacology 20020901 |
| Identification and comparative analysis of differentially expressed proteins in rat striatum following 6-hydroxydopamine lesions of the nigrostriatal pathway: up-regulation of amyloid precursor-like protein 2 expression. | The European journal of neuroscience 20020901 |
| Generation of dopaminergic neurons from embryonic stem cells. | Journal of neurology 20020901 |
| Change in bi-directional plasticity at CA1 synapses in hippocampal slices taken from 6-hydroxydopamine-treated rats: the role of endogenous norepinephrine. | The European journal of neuroscience 20020901 |
| Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. | Experimental neurology 20020901 |
| Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system. | Experimental neurology 20020901 |
| Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT. | NeuroImage 20020901 |
| Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion. | Neuroscience letters 20020830 |
| Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease. | Brain research 20020830 |
| Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. | Brain research. Developmental brain research 20020830 |
| Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. | The Journal of biological chemistry 20020823 |
| Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats. | Behavioural brain research 20020821 |
| Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020815 |
| Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure. | Circulation 20020813 |
| Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. | Neuroscience letters 20020809 |
| A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. | Brain research 20020802 |
| Comparison of fresh and cryopreserved porcine ventral mesencephalon cells transplanted in A rat model of Parkinson's disease. | Journal of neuroscience research 20020801 |
| Efficacy of elevated body swing test in the early model of Parkinson's disease in rat. | Physiology & behavior 20020801 |
| Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940. | Biochemical pharmacology 20020801 |
| The adult substantia nigra contains progenitor cells with neurogenic potential. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020801 |
| Forced nonuse in unilateral parkinsonian rats exacerbates injury. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020801 |
| Effect of 6-hydroxydopamine treatment in the area postrema on morphine-induced emesis in ferrets. | Japanese journal of pharmacology 20020801 |
| Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum. | Neurobiology of disease 20020801 |
| A novel rotometer based on a RISC microcontroller. | Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc 20020801 |
| [Participation of the brain catecholamines in changes in activity of the rat hypophyseal-adrenal system induced by hydrocortisone administration during neonatal ontogenesis]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20020801 |
| Aggravation of 6-hydroxydopamine-induced dopaminergic lesions in metallothionein-I and -II knock-out mouse brain. | Neuroscience letters 20020712 |
| Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. | Nuclear medicine and biology 20020701 |
| Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine. | Journal of neurochemistry 20020701 |
| Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020701 |
| Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. | Biochemical pharmacology 20020701 |
| L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. | Neurobiology of disease 20020701 |
| Evidence for a mutual interaction between noradrenergic and serotonergic agonists in stimulation of ACTH and corticosterone secretion in the rat. | Brain research 20020621 |
| Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation. | European journal of pharmacology 20020620 |
| High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020615 |
| Specific up-regulation of GADD153/CHOP in 1-methyl-4-phenyl-pyridinium-treated SH-SY5Y cells. | Journal of neuroscience research 20020615 |
| Morphological changes in immunopositive cells of ionotropic glutamate receptor subunits during the development of transplanted fetal ventral mesencephalic neurons. | Brain research 20020614 |
| Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020601 |
| Involvement of endogenous CRF in carbon tetrachloride-induced acute liver injury in rats. | American journal of physiology. Regulatory, integrative and comparative physiology 20020601 |
| Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. | The Journal of pharmacology and experimental therapeutics 20020601 |
| Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. | Experimental neurology 20020601 |
| Neurturin is a neuritogenic but not a survival factor for developing and adult central noradrenergic neurons. | Journal of neurochemistry 20020601 |
| Nucleus accumbens dopamine and discriminated approach learning: interactive effects of 6-hydroxydopamine lesions and systemic apomorphine administration. | Psychopharmacology 20020601 |
| [Glia conditioned medium offers protection against the toxicity induced by 6-OH-dopamine in vivo]. | Revista de neurologia 20020601 |
| Comparison of the efficacy of cell preparations from embryonic ventral mesencephalon of various prenatal age transplanted intrastriatally to rats with 6-OHDA-induced Parkinsonism. | Bulletin of experimental biology and medicine 20020601 |
| Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats. | Brain research 20020531 |
| Induction of tyrosine hydroxylase expression in rat fetal striatal precursor cells following transplantation. | Neuroscience letters 20020510 |
| Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501 |
| beta-Adrenergic modulation of muscarinic cholinergic receptor expression and function in developing heart. | American journal of physiology. Regulatory, integrative and comparative physiology 20020501 |
| Brain structures mediating the suckling stimulus-induced release of prolactin. | Journal of neuroendocrinology 20020501 |
| Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra. | Experimental neurology 20020501 |
| The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease. | Experimental neurology 20020501 |
| Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats. | Experimental neurology 20020501 |
| Involvement of dopaminergic system in the nucleus accumbens in the discriminative stimulus effects of phencyclidine. | Neuropharmacology 20020501 |
| Phencyclidine supersensitivity in rats with neonatal dopamine loss. | Psychopharmacology 20020501 |
| p38 MAP kinase is involved in lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures. | Annals of the New York Academy of Sciences 20020501 |
| Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology? | Journal of neural transmission (Vienna, Austria : 1996) 20020501 |
| Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat. | Movement disorders : official journal of the Movement Disorder Society 20020501 |
| [Effects of simultaneous transplant of foetal mesencephalic cells in the striatum and the subthalamic nucleus of hemiparkinsonian rats]. | Revista de neurologia 20020501 |
| The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585. | Brain research 20020426 |
| Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors. | European journal of pharmacology 20020419 |
| The rate of intravenous cocaine administration determines susceptibility to sensitization. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020415 |
| Differential effect of catecholamines and MPP(+) on membrane permeability in brain mitochondria and cell viability in PC12 cells. | Neurochemistry international 20020401 |
| In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020401 |
| Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion. | The Journal of pharmacology and experimental therapeutics 20020401 |
| Chemical sympathectomy has no effect on the severity of murine AIDS: murine AIDS alone depletes norepinephrine levels in infected spleen. | Brain, behavior, and immunity 20020401 |
| Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. | Experimental neurology 20020401 |
| Animal models of Parkinson's disease. | BioEssays : news and reviews in molecular, cellular and developmental biology 20020401 |
| Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens: commentary on Jackson and Cunnane. | British journal of pharmacology 20020401 |
| Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens. | British journal of pharmacology 20020401 |
| Sympathetic nervous system plays a major role in acute cold/restraint stress inhibition of host resistance to Listeria monocytogenes. | Journal of neuroimmunology 20020401 |
| Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. | Psychopharmacology 20020401 |
| 6-Hydroxydopamine lesioning differentially affects alpha-synuclein mRNA expression in the nucleus accumbens, striatum and substantia nigra of adult rats. | Neuroscience letters 20020329 |
| Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. | The Journal of comparative neurology 20020318 |
| Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease. | Biochimica et biophysica acta 20020316 |
| Glyceraldehyde-3-phospate dehydrogenase is translocated into nuclei through Golgi apparatus during apoptosis induced by 6-hydroxydopamine in human dopaminergic SH-SY5Y cells. | Neuroscience letters 20020315 |
| GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. | Neuroscience letters 20020315 |
| Central noradrenergic blockade prevents autotomy in rat: implication for pharmacological prevention of postdenervation pain syndrome. | Brain research bulletin 20020315 |
| Interactions of the neurotoxin 6-hydroxydopamine with glyceraldehyde-3-phosphate dehydrogenase. | Toxicology letters 20020310 |
| Protective effect of serotonin on 6-hydroxydopamine- and dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells. | Neurochemistry international 20020301 |
| Role of norepinephrine in the dorsomedial hypothalamic panic response: an in vivo microdialysis study. | Pharmacology, biochemistry, and behavior 20020301 |
| Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020301 |
| D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation. | The European journal of neuroscience 20020301 |
| Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. | The European journal of neuroscience 20020301 |
| Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum. | Journal of neural transmission (Vienna, Austria : 1996) 20020301 |
| Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. | Gene therapy 20020301 |
| Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. | Brain research. Developmental brain research 20020227 |
| Mesolimbic dopaminergic system is involved in diurnal blood pressure regulation. | Brain research 20020222 |
| Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. | Proceedings of the National Academy of Sciences of the United States of America 20020219 |
| Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism: involvement of hydrogen peroxide (H(2)O(2)), caspase-3, and nuclear factor kappa-B (NF-kappaB), p53, c-Jun transcription factors. | Biochemical pharmacology 20020215 |
| Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. | European journal of pharmacology 20020202 |
| Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats. | Molecular pharmacology 20020201 |
| MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats. | Brain research 20020201 |
| Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty. | Experimental neurology 20020201 |
| Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020201 |
| Inhibition of rat liver fibrogenesis through noradrenergic antagonism. | Hepatology (Baltimore, Md.) 20020201 |
| Intraplantar injection of glutamate evokes peripheral adenosine release in the rat hind paw: involvement of peripheral ionotropic glutamate receptors and capsaicin-sensitive sensory afferents. | Journal of neurochemistry 20020201 |
| Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice. | Cell and tissue research 20020201 |
| The effects of chemical sympathectomy on T-cell cytokine responses are not mediated by altered peritoneal exudate cell function or an inflammatory response. | Brain, behavior, and immunity 20020201 |
| Chemical sympathectomy alters numbers of splenic and peritoneal leukocytes. | Brain, behavior, and immunity 20020201 |
| Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. | Psychopharmacology 20020201 |
| Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector. | Neuroreport 20020121 |
| Effects of short- and long-acting dopamine agonists on sensitized dopaminergic neurotransmission in rats with unilateral 6-OHDA lesions. | Life sciences 20020118 |
| Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum. | Life sciences 20020118 |
| The reaction of nitric oxide with 6-hydroxydopamine: implications for Parkinson's disease. | Free radical biology & medicine 20020115 |
| MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. | Synapse (New York, N.Y.) 20020101 |
| Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. | Archives of biochemistry and biophysics 20020101 |
| Regulation of striatal neuropeptide mRNAs: effects of the 5-HT(2) antagonist SR46349B in adult rats with a neonatal 6-hydroxydopamine lesion. | Journal of neuroscience research 20020101 |
| Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. | Biochemical pharmacology 20020101 |
| Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease. | Experimental neurology 20020101 |
| Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. | Neurological research 20020101 |
| D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. | Neuroscience 20020101 |
| Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease - a functional magnetic resonance imaging study. | The European journal of neuroscience 20020101 |
| Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. | The European journal of neuroscience 20020101 |
| Study of the neurotransmitter dopamine and the neurotoxin 6-hydroxydopamine by electrospray ionization coupled with tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20020101 |
| Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease. | Journal of neurochemistry 20020101 |
| Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture. | Journal of neurochemistry 20020101 |
| Activation and differentiation of endogenous neural stem cell progeny in the rat Parkinson animal model. | Methods in molecular biology (Clifton, N.J.) 20020101 |
| Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance. | Neuroscience 20020101 |
| Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats. | Neuroscience 20020101 |
| A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting. | Cell transplantation 20020101 |
| Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. | Cell transplantation 20020101 |
| Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion. | Cell transplantation 20020101 |
| Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats. | Cell transplantation 20020101 |
| The effects of xenografts of dopamine-rich ganglia from the immature CNS of the mollusk Helix aspersa L. on learning time during acquisition of an operant food-procuring reflex in WAG/Rij rats. | Neuroscience and behavioral physiology 20020101 |
| Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease. | Neuroscience 20020101 |
| Interocular effect of intravitreal injection of 6-hydroxydopamine and dopamine on spinule formation in teleost retina. | Histology and histopathology 20020101 |
| Asymmetrical changes of excitatory synaptic transmission in dopamine-denervated striatum after transient forebrain ischemia. | Neuroscience 20020101 |
| Enhanced release of adenosine in rat hind paw following spinal nerve ligation: involvement of capsaicin-sensitive sensory afferents. | Neuroscience 20020101 |
| Detailed localization of regulator of G protein signaling 2 messenger ribonucleic acid and protein in the rat brain. | Neuroscience 20020101 |
| Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. | Amino acids 20020101 |
| Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration. | Amino acids 20020101 |
| Radiation and regeneration: behavioral improvement and GDNF expression after Gamma Knife radiosurgery in the 6-OHDA rodent model of hemi-parkinsonism. | Acta neurochirurgica. Supplement 20020101 |
| Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression. | Neuroscience 20020101 |
| Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia. | Neuroscience 20020101 |
| [Criteria of efficiency of transplantation of embryonic nervous tissue preparations in rats with 6-OHDA-impaired dopaminergic nigrostriatal system]. | Patologicheskaia fiziologiia i eksperimental'naia terapiia 20020101 |
| Critical periods of the dopaminergic system formation in rat brain. | Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20020101 |
| Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease. | Cell transplantation 20020101 |
| Histochemical properties of intrastriatal mesencephalic grafts. | Advances in experimental medicine and biology 20020101 |
| Protective effect of GSH on PD model induced by 6-OHDA in vitro. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20020101 |
| D2-dopamine receptor blockade modulates temporal resolution in goldfish. | Visual neuroscience 20020101 |
| Neonatal 6-hydroxydopamine administration to mice is fatal. | Developmental neuroscience 20020101 |
| [Myoelectric function, metabolism, intestinal circulation and vagal activity after chemical sympathectomy]. | Folia medica Cracoviensia 20020101 |
| Down-regulation of Bcl-2, activation of caspases, and involvement of reactive oxygen species in 6-hydroxydopamine-induced thymocyte apoptosis. | Neuroimmunomodulation 20020101 |
| Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20011215 |
| cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20011215 |
| 6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase. | Brain research 20011213 |
| Local capsaicin application to the stellate ganglion and stellatectomy attenuate neurogenic inflammation in rat bronchi. | Autonomic neuroscience : basic & clinical 20011210 |
| Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. | European journal of pharmacology 20011207 |
| Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. | Neuroreport 20011204 |
| Different effects of five catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. | Journal of agricultural and food chemistry 20011201 |
| Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201 |
| Role of dopaminergic system in core part of nucleus accumbens in hyperlocomotion and rearing induced by MK-801 in rats: a behavioral and in vivo microdialysis study. | Japanese journal of pharmacology 20011201 |
| 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease. | Cellular and molecular neurobiology 20011201 |
| Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra. | Brain research 20011130 |
| Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. | Cerebral cortex (New York, N.Y. : 1991) 20011101 |
| Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011101 |
| Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. | British journal of pharmacology 20011101 |
| Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. | Alcoholism, clinical and experimental research 20011101 |
| The role of dopamine transporter imaging agent [99mTc]TRODAT-1 in hemi-parkinsonism rat brain. | Nuclear medicine and biology 20011101 |
| Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine. | The European journal of neuroscience 20011101 |
| Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain. | Movement disorders : official journal of the Movement Disorder Society 20011101 |
| Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers. | European journal of pharmacology 20011019 |
| Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20011015 |
| Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants. | Free radical biology & medicine 20011015 |
| Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. | European journal of pharmacology 20011005 |
| Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. | Progress in neurobiology 20011001 |
| Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice. | Parkinsonism & related disorders 20011001 |
| Future of neuroprotection in Parkinson's disease. | Parkinsonism & related disorders 20011001 |
| The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011001 |
| Influence of alternating low frequency magnetic fields on reactivity of central dopamine receptors in neonatal 6-hydroxydopamine treated rats. | Bioelectromagnetics 20011001 |
| Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. | Experimental neurology 20011001 |
| Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats. | Molecular therapy : the journal of the American Society of Gene Therapy 20011001 |
| Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. | Journal of neurochemistry 20011001 |
| Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine. | Journal of Korean medical science 20011001 |
| LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats. | Synapse (New York, N.Y.) 20011001 |
| Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats. | Synapse (New York, N.Y.) 20011001 |
| Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease. | The European journal of neuroscience 20011001 |
| Effects of nerve growth factor on expression of GAP-43 in right atria after sympathectomy in diabetic rats. | Diabetes, obesity & metabolism 20011001 |
| Unilateral striatal dopamine depletion: time-dependent effects on cortical function and behavioural correlates. | The European journal of neuroscience 20011001 |
| Erectile dysfunction occurs following substantia nigra lesions in the rat. | International journal of impotence research 20011001 |
| Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons. | Synapse (New York, N.Y.) 20010915 |
| NMDA receptor antagonism modifies the synergistic regulation of striatal tachykinin gene expression induced by dopamine D(1) and serotonin(2) receptor stimulation following neonatal dopamine depletion. | Brain research. Molecular brain research 20010910 |
| In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions. | Experimental neurology 20010901 |
| A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. | Experimental neurology 20010901 |
| Dopamine D3 receptors are involved in amphetamine-induced contralateral rotation in 6-OHDA lesioned rats. | Pharmacology, biochemistry, and behavior 20010901 |
| MPP(+) downregulates mitochondrially encoded gene transcripts and their activities in dopaminergic neuronal cells: protective role of Bcl-2. | Biochemical and biophysical research communications 20010824 |
| 6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells. | Biochemical pharmacology 20010815 |
| Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion. | Brain research. Molecular brain research 20010815 |
| Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010815 |
| Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010815 |
| In vitro generation and transplantation of precursor-derived human dopamine neurons. | Journal of neuroscience research 20010815 |
| Hemorrhage activates catecholaminergic neurons sensitive to GABA in the nucleus of the solitary tract with ascending projections to the subfornical organ in rats. | Autonomic neuroscience : basic & clinical 20010813 |
| Enhanced excitatory synaptic transmission in spiny neurons of rat striatum after unilateral dopamine denervation. | Neuroscience letters 20010810 |
| Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. | Brain research 20010803 |
| Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010801 |
| Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010801 |
| Effects of lesioning noradrenergic neurones in the locus coeruleus on conditioned and unconditioned aversive behaviour in the rat. | Progress in neuro-psychopharmacology & biological psychiatry 20010801 |
| 6-hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation. | Journal of neurochemistry 20010801 |
| Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats. | Neurobiology of disease 20010801 |
| [Influence of adrenergic denervation on uterine contractility of pregnant rats in vitro]. | Acta pharmaceutica Hungarica 20010801 |
| Validity of a quantitative technique to study striatal dopaminergic neurodegeneration by in vivo microdialysis. | Journal of neuroscience methods 20010730 |
| A possible indirect sympathomimetic action of metformin in the arterial vessel wall of spontanously hypertensive rats. | Life sciences 20010720 |
| Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. | Neuron 20010719 |
| The role of dopamine receptors in regulating the size of axonal arbors. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010715 |
| Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals. | Journal of neuroscience methods 20010715 |
| Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease. | Behavioural brain research 20010701 |
| The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. | Journal of neurochemistry 20010701 |
| Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats. | The European journal of neuroscience 20010701 |
| Differential effects of unilateral striatal and nigrostriatal lesions on grip strength, skilled paw reaching and drug-induced rotation in the rat. | Brain research bulletin 20010701 |
| Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. | The European journal of neuroscience 20010701 |
| NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease. | The European journal of neuroscience 20010701 |
| Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. | The International journal of neuroscience 20010701 |
| Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation. | Brain research 20010629 |
| Peripheral target contact regulates Ca2+ channels in the cell bodies of bullfrog sympathetic ganglion B-neurons. | Autonomic neuroscience : basic & clinical 20010620 |
| Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010615 |
| 2,4,5-Trichlorophenoxyacetic acid inhibits apoptosis in PC12 cells. | Life sciences 20010615 |
| Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. | Brain research 20010615 |
| Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease. | Brain research 20010615 |
| (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release. | European journal of pharmacology 20010615 |
| Cholecystokinin-8 promotes recovery of sympathectomy induced by 6-hydroxydopamine in adult mice. | Neuroreport 20010613 |
| Entopeduncular lesions facilitate and thalamic lesions depress spontaneous and drug-evoked motor behavior in the hemiparkinsonian rat. | Synapse (New York, N.Y.) 20010601 |
| The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010601 |
| Free 3-nitrotyrosine causes striatal neurodegeneration in vivo. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010601 |
| Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010601 |
| Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. | Experimental neurology 20010601 |
| Animal model of neuropathic tachycardia syndrome. | Hypertension (Dallas, Tex. : 1979) 20010601 |
| Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo. | Journal of neurochemistry 20010601 |
| Central and peripheral catecholamines regulate the exercise-induced elevation of plasma interleukin 6 in rats. | Life sciences 20010601 |
| Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022. | Annals of the New York Academy of Sciences 20010601 |
| A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. | Journal of neuroscience methods 20010530 |
| Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine. | Brain research 20010525 |
| Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010515 |
| Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine. | Brain research bulletin 20010515 |
| Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. | Neuroscience letters 20010511 |
| 6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum. | Neuroreport 20010508 |
| BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. | Nature 20010503 |
| Evidence for a direct action of Tityus serrulatus scorpion venom on the cardiac muscle. | Toxicon : official journal of the International Society on Toxinology 20010501 |
| Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat. | Synapse (New York, N.Y.) 20010501 |
| Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. | Experimental neurology 20010501 |
| Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration. | Experimental neurology 20010501 |
| Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions. | Experimental neurology 20010501 |
| Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease. | Experimental neurology 20010501 |
| Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. | The European journal of neuroscience 20010501 |
| Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. | Journal of neurochemistry 20010501 |
| Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. | Neuropharmacology 20010501 |
| Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats. | Neuropharmacology 20010501 |
| Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis. | Archives of biochemistry and biophysics 20010501 |
| Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions. | Movement disorders : official journal of the Movement Disorder Society 20010501 |
| Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells. | The European journal of neuroscience 20010501 |
| Convergent functional genomics: application to bipolar disorder. | Annals of medicine 20010501 |
| Preclinical models of Parkinson's disease. | Current protocols in neuroscience 20010501 |
| Ribozyme-mediated inhibition of caspase-3 activity reduces apoptosis induced by 6-hydroxydopamine in PC12 cells. | Brain research 20010427 |
| Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats. | Brain research 20010427 |
| Circadian rhythm of drinking and running-wheel activity in rats with 6-hydroxydopamine lesions of the ventral tegmental area. | Brain research 20010427 |
| Effect of 6-hydroxydopamine or repeated amphetamine treatment on mesencephalic mRNA levels for AMPA glutamate receptor subunits in the rat. | Neuroscience letters 20010420 |
| Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010415 |
| Lesion of the bulbospinal noradrenergic pathways blocks desipramine-induced inhibition of the C-fiber evoked nociceptive reflex in rats. | Neuroscience letters 20010413 |
| NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats. | Brain research 20010406 |
| Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. | The Journal of comparative neurology 20010402 |
| Changes in the gene expression of GABA(A) receptor alpha1 and alpha2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts. | Experimental neurology 20010401 |
| Retrograde tracing techniques influence reported death rates of adult rat nigrostriatal neurons. | Experimental neurology 20010401 |
| Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. | Journal of neurochemistry 20010401 |
| Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia. | Neurobiology of disease 20010401 |
| Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. | The European journal of neuroscience 20010401 |
| [3H]acetycholine release in rat striatal slices is not subject to dopamine heteroreceptor supersensitivity 30 months after 6-hydroxydopamine lesion of the substantia nigra. | Naunyn-Schmiedeberg's archives of pharmacology 20010401 |
| Intracerebral administration of 2,4-diclorophenoxyacetic acid induces behavioral and neurochemical alterations in the rat brain. | Neurotoxicology 20010401 |
| Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat. | Neurotoxicology 20010401 |
| Central norepinephrine pathways are involved in cardiovascular response to intracerebroventricular substance P. | Acta pharmacologica Sinica 20010401 |
| Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism. | Journal of neuroscience methods 20010330 |
| The pasta matrix reaching task: a simple test for measuring skilled reaching distance, direction, and dexterity in rats. | Journal of neuroscience methods 20010330 |
| Neuroprotective effects of GDNF against 6-OHDA in young and aged rats. | Brain research 20010330 |
| Modulation of visceral nociceptive responses of rat spinal dorsal horn neurons by sympathectomy. | Neuroreport 20010326 |
| Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. | Brain research 20010302 |
| 6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins. | Experimental neurology 20010301 |
| IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. | Experimental neurology 20010301 |
| Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice. | Journal of neurochemistry 20010301 |
| Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes. | Journal of neuroimmunology 20010301 |
| Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion. | Journal of neurophysiology 20010301 |
| Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. | Synapse (New York, N.Y.) 20010301 |
| Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease. | The European journal of neuroscience 20010301 |
| Effect of chemical sympathectomy with 6-hydroxydopamine on osteoclast activity in the gerbilline middle ear bulla. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20010301 |
| Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. | Pharmacopsychiatry 20010301 |
| Effect of dopamine depletion on DARPP-32 protein in ischemic rat striatum. | Acta pharmacologica Sinica 20010301 |
| [Effect of alpha-lipoic acid on the apoptosis of PC12 cells induced by 6-hydroxydopamine]. | Shi yan sheng wu xue bao 20010301 |
| Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. | Brain research 20010216 |
| Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion. | Brain research 20010209 |
| Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism. | Journal of neuroimmunology 20010201 |
| Microglial response to the neurotoxicity of 6-hydroxydopamine in neonatal rat cerebellum. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20010201 |
| Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1beta-induced hypothalamic pituitary adrenal axis responses. | Neuroendocrinology 20010201 |
| Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201 |
| Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201 |
| Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201 |
| Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201 |
| Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats. | Brain research 20010126 |
| Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity. | Neuroreport 20010122 |
| Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010115 |
| The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats. | Neuroscience letters 20010112 |
| Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra. | Brain research 20010112 |
| Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine. | Synapse (New York, N.Y.) 20010101 |
| Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor. | The European journal of neuroscience 20010101 |
| The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats. | The European journal of neuroscience 20010101 |
| Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010101 |
| Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration. | Experimental neurology 20010101 |
| Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease. | Experimental neurology 20010101 |
| Serotonergic heterotypic sprouting in the unilaterally dopamine-depleted mouse neostriatum. | Developmental neuroscience 20010101 |
| Septal cholinergic neurons suppress seizure development in hippocampal kindling in rats: comparison with noradrenergic neurons. | Neuroscience 20010101 |
| Ingrowth of sympathetic innervation occurs concomitantly with a decrease of ANP in the growing rat cardiac ventricles. | Anatomy and embryology 20010101 |
| High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. | Journal of neuropathology and experimental neurology 20010101 |
| Co-transmitter function of ATP in central catecholaminergic neurons of the rat. | Neuroscience 20010101 |
| Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents. | Brain research bulletin 20010101 |
| Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons. | Neuroscience 20010101 |
| Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes. | Neuroscience 20010101 |
| Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study. | Journal of neural transmission (Vienna, Austria : 1996) 20010101 |
| Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. | Journal of neural transmission (Vienna, Austria : 1996) 20010101 |
| Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum. | Neuroscience 20010101 |
| Dopamine depletion with 6-OHDA enhances dopamine D1-receptor modulation of potassium currents in retinal bipolar cells. | Visual neuroscience 20010101 |
| Nigrostriatal dopaminergic denervation enhances dopamine D(4) receptor binding in rat caudate-putamen. | Pharmacology, biochemistry, and behavior 20010101 |
| Influence of social isolation and 6-OHDA lesion on the effects of quinelorane. | Pharmacology, biochemistry, and behavior 20010101 |
| Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant material. | Journal of neural transmission (Vienna, Austria : 1996) 20010101 |
| Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum. | Neuroscience 20010101 |
| Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor. | Neuroscience 20010101 |
| Regional differences in the expression of corticostriatal synaptic plasticity. | Neuroscience 20010101 |
| Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. | Neuroscience 20010101 |
| Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment. | Neuroscience 20010101 |
| [Effect of chemical sympathectomy on myoelectric activity of the small bowel]. | Folia medica Cracoviensia 20010101 |
| Noradrenergic inhibition of TNF upregulation in hemorrhagic shock. | Neuroimmunomodulation 20010101 |
| Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat. | Redox report : communications in free radical research 20010101 |
| 6-Hydroxydopamine infusions into the structures of mesolimbic dopaminergic system alter the memory enhancing effect of CK-8US and caerulein in rats. | Folia histochemica et cytobiologica 20010101 |
| Effect of interleukin 1beta on rat thymus microenvironment. | European journal of histochemistry : EJH 20010101 |
| Behavioral alterations after unilateral 6-hydroxydopamine lesions of the striatum. Effect of alpha-tocopherol. | Polish journal of pharmacology 20010101 |
| Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental parkinsonism. | Functional neurology 20010101 |
| Regulation of EphB1 expression by dopamine signaling. | Brain research. Molecular brain research 20001228 |
| Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. | Experimental neurology 20001101 |
| Expression of metallothionein-III mRNA and its regulation by levodopa in the basal ganglia of hemi-parkinsonian rats. | Neuroscience letters 20001020 |
| Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. | Synapse (New York, N.Y.) 20000901 |
| Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. | Pharmacology, biochemistry, and behavior 20000801 |
| Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys. | Pharmacology, biochemistry, and behavior 20000301 |
| Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia. | Neuroscience 20000101 |
| The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats. | Journal of neural transmission (Vienna, Austria : 1996) 20000101 |
| Cocaine-induced hypertension: role of the peripheral sympathetic system. | Pharmacological research 19990801 |
| Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. | Journal of neuroscience research 19990701 |
| The toxicity of 6-hydroxydopamine on PC12 and P19 cells. | Brain research. Molecular brain research 19990521 |
| Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage. | Brain research 19990213 |
| Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions. | Journal of neuroscience research 19990101 |
| Role of sympathetic nervous system in experimental hypertension and diabetes mellitus. | Clinical and experimental hypertension (New York, N.Y. : 1993) 19990101 |
| Involvement of 5-HT6 receptors in nigro-striatal function in rodents. | British journal of pharmacology 19981201 |
| Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. | Journal of neuroscience research 19981015 |
| Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity. | The Journal of neuroscience : the official journal of the Society for Neuroscience 19981001 |
| L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. | The European journal of neuroscience 19980801 |
| Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells. | Journal of neurochemistry 19980601 |
| Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Experimental neurology 19980601 |
| Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. | Annals of neurology 19980501 |
| Nitric oxide synthase is co-localized with vasoactive intestinal polypeptide in postganglionic parasympathetic nerves innervating the rat vas deferens. | Neuroscience 19980301 |
| Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats. | Acta medica Okayama 19980201 |
| Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. | Journal of medicinal chemistry 19970523 |
| Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. | Naunyn-Schmiedeberg's archives of pharmacology 19970501 |
| Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431. | European journal of pharmacology 19961219 |
| Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum. | Neuroscience 19961201 |
| Picrotoxin induces both hypertension and dopamine release in the rat amygdala. | Neuroscience letters 19961108 |
| The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice. | Pharmacology, biochemistry, and behavior 19960901 |
| Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats. | Journal of cardiovascular pharmacology 19960801 |
| Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra. | Brain research 19960701 |
| Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. | The European journal of neuroscience 19960201 |
| Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine. | Neuroscience 19950501 |
| Activation of arc, a putative 'effector' immediate early gene, by cocaine in rat brain. | Journal of neurochemistry 19950501 |
| A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. | Proceedings of the National Academy of Sciences of the United States of America 19950227 |
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. | Nature genetics 19941001 |
| Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli. | Brain research 19940404 |
| The role of activation of the sympathetic nervous system in the central pressor action of calcitonin gene-related peptide in conscious rats. | Naunyn-Schmiedeberg's archives of pharmacology 19940401 |
| Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy. | Neuropharmacology 19930301 |
| Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19920901 |
| Upregulation of postsynaptic dopamine receptors in the striatum does not influence haloperidol-induced catalepsy in mice. | Pharmacology, biochemistry, and behavior 19920801 |
| Baroreflex changes produced by serotonergic or catecholaminergic lesions in the rat nucleus tractus solitarius. | The Journal of pharmacology and experimental therapeutics 19920401 |
| Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital. | Brain research. Developmental brain research 19890801 |
| Endogenous opiate system and dihydropyridine-induced central regulation of sympathetic tone in rats. | European journal of pharmacology 19881206 |
| Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala. | Psychopharmacology 19880101 |
| Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes. | European journal of pharmacology 19870626 |
| Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. | European journal of pharmacology 19870317 |
| The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5). | Journal of the autonomic nervous system 19870301 |
| Pharmacological characterization of spinal alpha adrenoceptors related to blood pressure control in rats. | The Journal of pharmacology and experimental therapeutics 19870101 |
| Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol. | Neuropharmacology 19870101 |
| Cerebrovascular permeability to horseradish peroxidase in hypertensive rats: effects of unilateral locus ceruleus lesion. | Acta neuropathologica 19870101 |
| Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study. | Naunyn-Schmiedeberg's archives of pharmacology 19861101 |
| 6-Hydroxydopamine treatment enhances excitation of cultured cerebellar neurons by glutamate. | Canadian journal of physiology and pharmacology 19861001 |
| Transient contralateral rotation following unilateral substantia nigra lesion reflects susceptibility of the nigrostriatal system to exhaustion by amphetamine. | Life sciences 19860707 |
| Effect of 6-OHDA injected into the locus coeruleus on apomorphine-induced aggression. | Pharmacology, biochemistry, and behavior 19860301 |
| Modulation of peripheral beta-1 and alpha-2 receptor sensitivities by the administration of the tricyclic antidepressant, imipramine, alone and in combination with alpha-2 antagonists to rats. | The Journal of pharmacology and experimental therapeutics 19860201 |
| Chemical lesions of the nucleus accumbens septi in rats: effects on muricide and apomorphine-induced aggression. | Behavioural brain research 19860201 |
| Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. | Psychopharmacology 19860101 |
| DOCA-salt induced myocardial sensitization to ventricular fibrillation by isoprenaline in rats. Role of the autonomic nervous system. | Journal of autonomic pharmacology 19851201 |
| Components of functional sympathetic control of heart rate in neonatal rats. | The American journal of physiology 19850501 |
| Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. | European journal of pharmacology 19840817 |
| Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. | European journal of pharmacology 19840713 |
| Functional recovery following transplantation of ventral mesencephalic cells in rat subjected to 6-OHDA lesions of the mesolimbic dopaminergic neurons. | Brain research 19840618 |
| Irritable aggression induced by delta 9-tetrahydrocannabinol in rats pretreated with 6-hydroxydopamine. | Pharmacology, biochemistry, and behavior 19840301 |
| Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat. | Life sciences 19840227 |
| On some central effects of elymoclavine. | Acta physiologica et pharmacologica Bulgarica 19840101 |
| Electrophysiological effects of ouabain in 6-hydroxydopamine pretreated dogs. | Canadian journal of physiology and pharmacology 19830301 |
| Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. | Brain research 19820722 |